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To initiate colonization and infection, most microbial pathogens must first recognize and adhere 
to cells in the host tissues. Adherence inhibition, therefore, can be used as a strategy for 
preventing infectious disease.  Prebiotic carbohydrates, in addition to their ability to influence the 
colonic microbiota, are also able to inhibit attachment of pathogenic bacteria to the epithelial cells 
that line the intestinal tract. However, the mechanism for this inhibition is not well understood, in 
part, because the receptor sites on the target cells have not been identified.  In this research, we 
developed a simplified model using plant lectins and HEp-2 tissue culture cells to simulate 
bacterial adhesins-receptors interactions and to identify putative ligands located on the surface of 
target cells. The effect of lectin cognate ligands and two prebiotic carbohydrates, 
galactooligosaccharide (GOS) and polydextrose (PDX) was measured with this approach.  We 
hypothesized that GOS would inhibit adherence of those lectins whose cognate ligands were 
structurally similar to GOS.  All of the lectins that were able to bind to the target cells were 
inhibited by nearly 100% in the presence of 1 mg/ml of the cognate ligands. When prebiotics 
were added, inhibition of lectin binding was also observed. The inhibition was generally 
proportional to the structural similarity between the prebiotic and the cognate ligands. In 
particular, GOS significantly inhibited attachment of most of the lectins, consistent with the 
established role of GOS as an anti-adherence agent. In contrast, PDX did not significantly inhibit 
attachment of lectins, suggesting that it is structurally dissimilar to the HEp-2 receptor sites.  The 
results support the hypothesis that cell binding inhibition is caused by competition of the GOS for 
the lectin. Subsequent anti-adherence experiments were completed to assess the anti-adherence 
properties of several bovine colostrum fractions against four different bacterial strains, 
enteropathogenic Escherichia coli, enterotoxigenic Escherichia coli, Cronobacter sakazakii and 
Salmonella enterica serovar Typhimurium. An ultrafiltration permeate and an oligosaccharide 
fraction significantly inhibited binding of all four pathogens to HEp-2 tissue culture cells. In 
contrast, a nanofiltration retentate inhibited Salmonella adherence, but not other pathogens, while 
a colostrum whey fraction had no effect for any of the test organisms. The effectiveness of the 
inhibitory fractions was mainly attributed to the presence of oligosaccharides and/or peptides, 
although lactose may have also contributed to adherence inhibition. Several methods for 
extracting oligosaccharides and removing lactose from bovine colostrum were evaluated.  
Enzymatic hydrolysis and microbial fermentation were effective methods for degrading lactose. 
In contrast, the physical-chemical separation methods (i.e. crystallization, affinity 
chromatography and nano-filtration) were limited in their ability to separate and enrich 
oligosaccharides from bovine colostrum.  The results obtained from this study provide evidence 
to support the concept that bovine milk components can promote consumer health by preventing 
or reducing enteric infections.  These constituents could be used as antimicrobial agents in foods 
and/or in pharmacological applications. In particular, bovine colostrum whey appears to be a 
suitable source for these bioactive compounds.  
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Preface 
This thesis is comprised of five chapters. Chapter 1 provides a review of the current literature on 
general principles of bacterial adherence, strategies for preventing bacterial adherence, and the 
application of milk oligosaccharides as inhibitory agents. Chapter 2 describes a study on the 
effect of prebiotic carbohydrates on the binding kinetics of lectins to epithelial tissue culture cells.  
In Chapter 3, our efforts to separate oligosaccharides and remove or degrade lactose from bovine 
colostrum are described.  Chapter 4 describes results obtained when assessing the anti-adherence 
effect of colostrum oligosaccharides and several commercial colostrum whey fractions against 
enteropathogenic Escherichia coli, enterotoxigenic Escherichia coli, Enterobacter sakazakii and 
Salmonella enterica serovar Typhymurium. Chapter 5 provides a conclusion section that 
summarizes the major research findings presented in this thesis. 
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General principles of bacterial adherence, strategies for its prevention and the use of milk 
oligosaccharides as inhibitor agents. 
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1. Introduction  
For most bacterial pathogens, recognition and adhesion to the host cells are essential to 
initiate colonization and infection.  The importance of adherence in microbial virulence and 
pathogenesis has led to considerable research on understanding the specific structures and 
mechanisms involved in these processes.   In this review, the structural features and general 
principles involved in bacterial adherence to host cells will be reviewed. Strategies for preventing 
bacterial adhesion and preventing or reducing bacterial infections will also be described. In 
particular, the use of receptor analogs to block or interfere with pathogen-host cell interactions 
will be discussed.   This discussion will include descriptions of natural and synthetic glycans that 
have shown to be effective against bacterial pathogens, such as oligosaccharides derived from 
milk and colostrum.   Potential techniques to obtain these oligosaccharides will be described.  
 
2. Bacterial Adhesion 
Virtually all microbial pathogens must adhere to the surface of host tissue cells in order to 
initiate infections.  The adherence step serves several important functions.  First it provides a 
basis for tissue recognition such that the bacterium is able to adhere to specific target cells.  In 
addition, adherence provides resistance against environmental shear forces, such as those that 
occur in the intestinal tract and that would otherwise cause the bacteria to become displaced.  
While bacteria are bound to the host surfaces their ability to acquire nutrients increases, which 
further enhances their ability to survive and invade the host.  Attachment also gives the bacteria 
substantially greater resistance to the clearance and killing by immune factors, bacteriolytic 
enzymes and antibiotics. 
To facilitate adherence, Van der Waal’s and Coulombic forces bring the bacteria to close 
proximity to the host mucosal surface (Busscher & Weerkamp 1987).  Then hydrophobic 
interactions reversibly bind the microorganism to the surface of the epithelial cell (Ofek, Hasty et 
al. 2003).  These early non-specific events are followed by more permanent and more specific 
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adherence events.  The latter are mediated by structures on the bacterial surface, called adhesins, 
and their complementary ligands located on the mucosal surface of the host.  This highly 
stereospecific interaction leads to a firm adhesion (Ofek & Sharon 1990; Hasty et al. 1992; Ofek 
& Doyle 1994; McCoy et al. 1994; Ofek, et al. 2003).  Detachment would be expected only when 
all the adhesin-receptor interactions are coordinately reversible, the probability of which is low 
(Ofek et al. 2003). 
It is also worth noting that adherence and molecular target motifs can be found not only 
in naturally occurring cells and tissues, but also in coated abiotic materials such as glass and 
plastic. The latter case is especially important in industrial environments, since bacterial biofilms 
contaminate work surfaces and are the cause of clogged tubes and machinery (Kumar and Anand, 
1998; Mattila-Shadholm and Wirtanen, 1992) 
 
2.1. Adhesins 
Adhesins are specialized components or appendages common to many bacteria. Typically 
protein in nature, adhesins recognize and bind very specific receptors on the surface of the target 
host cells.  Adhesins, therefore, are the primary means for determining tissue tropism of the 
pathogen.  For many bacterial pathogens, adhesins are considered as essential virulence factors 
that are required for the bacteria to infect mucosal tissues in the respiratory, urinary and 
gastrointestinal tracts (Connell et al. 1997; Klemm et al. 2006, 2007; Roos et al. 2006).   
Although, many bacterial pathogens have the ability to express different adhesins, each adhesin is 
often expressed at different stages during infection.  It is the concerted action of the different 
adhesins that allows infections to occur (Klemm et al., 2010).  
There are three types of adhesin-receptor interactions, based on differences in the 
chemical nature of the adhesin-ligand reaction (Figure 1). The first type is similar to the classic 
lectin-carbohydrate interaction that is common in the plant kingdom (section 3).  Glycan 
recognition is mediated either by a lectin on the bacterial surface or a lectin on the host surface. 
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Among bacterial pathogens, the former predominates and contains the largest group of adhesins 
so far described.  The second category involves recognition between a protein on the surface of 
the bacteria and a complementary protein on the mucosal surface (e.g. Streptococcus pyogenes 
protein F binds to fribonectin).  The third type, involves the binding between hydrophobins.  A 
hydrophobin is a molecule or location on the bacterial surface that is involved in adhesion by 
interacting via hydrophobic structures.  Commonly, these interactions are mediated via lipids and 
hydrophobic moieties of proteins.  Hydrophobic adhesion has not received much attention 
because it is usually responsible for weak and reversible interactions that are difficult to measure 
(Ofek et al. 2003). 
 Molecular structures of bacterial adhesins. For adhesins to bind to the target moiety it 
is necessary that they be positioned at the exterior of the cell.  Many adhesins, including the auto 
transporter adhesins TibA and AIDA of E. coli, are located directly on the bacterial surface (Benz 
and Schmidt, 1992; Sherlock et al., 2004, 2005). However, proximity of the adhesin to the “body” 
of the cell can cause steric hinderance and reduce the interaction between the ligand and the 
receptor.  To solve this problem, bacteria have evolved numerous ways to position adhesins and 
maximize successful interactions. Most bacterial adhesins are organized as thin thread-like 
organelles called fimbriae or pili. Indeed, a majority of gram-negative and gram-positive 
pathogens produce these structures (Foster 2004, Odenbreit 2005; Pizarro-Cerda and Cossart 
2006).  Fimbriae are heteropolymers with lengths of about 1.0 µm.  They are composed of a 
structural protein, which serves as a platform for display of the actual adhesin which is located in 
the tip of the organelle (Hahn et al. 2002; Klemm et al. 2010, Klemm and Schembri 2000).  
Fimbriae can be evenly distributed over the surface of the bacterium; however, in some cases they 
are located preferentially on one part of the bacterial surface (Ofek et al., 2003).  Based on their 
morphological appearance, fimbriae have been classified according to four general categories: (1) 
Fimbriae with rigid structures measuring approximately 7 nm in diameter with various lengths 
(e.g., type 1 and P fimbriae); (2) Thin, flexible fimbriae of 2 or 3 nm in diameter (e.g., 987P 
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fimbriae); (3) Thinner and much more flexible structures such as curli; and (4) Type IV fimbriae, 
usually flexible pili of 4 to 6 nm in diameter which often form in bundles (Orskov and Orskov, 
1990).  
Finally, there are several non-fimbriae surface materials that have also been implicated in 
bacterial attachment, but that lack a specific target molecule.  Included are capsules, 
lipopolysaccharides, flagella and cellulose.  Not all the species of bacteria or even all the strains 
produce them.  
 
2.2. Enteric pathogens adhesion 
2.2.1. Enteropathogenic E. coli (EPEC) 
Enteropathogenic Escherichia coli (EPEC) is one of several pathovars of E. coli that 
cause disease in humans.  Worldwide, EPEC is a leading cause of infant diarrhea. A characteristic 
mechanism of EPEC pathogenesis is the formation of attaching and effacing (A/E) lesions.  A/E 
lesions are characterized by a series of events that include the destruction of the intestinal 
microvilli, intimate adherence of bacteria to the epithelium, formation of a pedestal, and 
aggregation of actin and other constituents of the cytoskeleton. The genes that encode for the 
production of A/E factors are located on the locus of enterocyte effacement (LEE) (McDaniel et 
al., 1995). The expression of this island of pathogenicity results in the synthesis of intimin, a type 
III secretion system, a number of secreted (Esp) proteins, and Tir, the translocated intimin 
receptor (Nataro and Kaper 1998). The intimate adherence of the EPEC is mediated by the outer 
membrane intimin, which is encoded by the eae gene. Intimin binds the protein Tir, which is 
inserted into the host cells membrane to serve as receptor (Kenny et al., 1997).  
Adherence of EPEC to host cells follows a pattern called localized adherence (LA).  In 
LA, bacteria bind to the tissue culture cells as microcolonies or bacterial clusters (Scaletsky et al., 
1984). This pattern is associated with the presence of the EAF plasmid which encode for a 
bundle-forming pili (BFP).  BFP is responsible for interconnecting bacteria within microcolonies 
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and therefore promote colony stabilization. EAF enhances the efficiency of A/E lesions, but is not 
essential for their formation. Furthermore, different EPEC strains show diverse adherence 
patterns besides LA; these include localized-like adherence (LAL), diffuse adherence pattern 
(DA) or aggregative adherence pattern. Each is mediated by different adhesins;  LAL is mediated 
mainly by intimin, DA  by the Afa adhesin and AA by an aggregative adhesin (Pelayo et al., 1999,  
Trabulsi et al., 2002).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
It has been suggested that flagella and flagellins of EPEC also contribute to adherence. 
EPEC flagella bind to mucins present in the gastrointestinal tract at the mucosal surface. In 
addition, EPEC flagella also have affinity for Extracellular Matrix (ECM) proteins, collagen, 
laminin, and fibronectin. The ability to bind ECM proteins could contribute to host colonization 
when the intestinal barrier is disrupted (Erdem et al., 2007). 
 
2.2.2.Enterotoxigenic E. coli (ETEC) 
ETEC is the most common cause of food and water-borne E. coli-mediated human 
diarrhea worldwide. It is also responsible for traveler’s diarrhea.  ETEC infections occur in 
animals as well, and the organism is a major problem for animal producers since it attacks pigs 
and calves, resulting in significant financial losses. ETEC adhere to the microvilli of the small 
intestinal epithelial cells, and although morphological lesions are not produced, enterotoxins are 
secreted that act locally on the enterocytes. (Nagy and Fekete, 1999. Among the major 
determinants of ETEC virulence are the plasmid-encoded colonization factors (CF) (Yamamoto 
& Yokota, 1983; Echeverria et al., 1986), surface structures that allow bacteria to attach to the 
intestinal mucosa. In addition, there are several non-CF chromosomally-encoded virulence factors 
that are implicated with ETEC virulence (Turner et al., 2006). It has been suggested that CFs may 
be responsible for bringing the bacterium closer to the cell, and once the bacterium is closer, non-
CF virulence factors will enhance the strength and intimacy of the interaction (Turner et al., 
2006). 
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Colonization factors.  More than 20 CFs have been identified and characterized. 
Usually, a four-gene operon encodes for these CFs. Expression of these genes results in the 
biosynthesis of a periplasic chaperone, an outer membrane usher protein, a major fimbrial 
subunit, and a minor subunit. The minor subunit, which is located in the tip of the fimbriae, is 
responsible for the binding of the bacteria to the host cell receptor.  Only a few cognate receptors 
of the CFs are fully characterized. That there is a large number of different CFs suggests that 
there is a vast diversity of receptors, which makes the identification and characterization of the 
adhesin ligands more complicated.  It is known that CFs receptors are glycoconjugates in the 
eukaryotic cells’ membrane. The type of oligosaccharide structure present in the glycoconjugates 
confer ETEC specificity towards tissues and cells (Lindahl and Wadstrom, 1984; Blomberg et al., 
1993; Erickson et al., 1994). 
 
2.2.3. Salmonella enterica serotype Typhimurium  
Salmonella Typhimurium is responsible for a systemic infection referred to as murine 
typhoid fever. Fimbriae are important virulence factors in Salmonella Typhimurium and are 
involved in invasion and the stimulation of an inflammatory response.  Four distinct fimbrial 
operons have been characterized, referred to as fim, lpf, pef and agf (Baumler et al.,1995; Clegg 
et al., 1987; Collinson et al., 1996; Friedrich et al., 1993). Mutations in individual fimbrial 
biosynthesis genes result in only a slight decrease of S. Typhimurium virulence.  This suggests 
that the absence of any adhesin can be compensated by the use or synthesis of alternate adhesins. 
When all of the fimbrial operons are inactivated, virulence in mice is reduced significantly, 
however, Salmonella is still able to adhere to the host cells and cause lethal infection (Velden et 
al., 1998). 
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2.2.4. Enterobacter sakazakii  
E. sakazakii is an opportunistic pathogen responsible for causing meningitis, necrotizing 
enterocolitis, and sepsis, especially in neonates.  These are very serious infections, with mortality 
rates ranging from 40 to 80%.  Dried infant formula is the principal product associated with E. 
sakazakii infections.   Information on the mechanisms of pathogenicity is limited. Two types of 
adhesion patterns, mixed pattern and localized adherence, have been observed, in vitro, using 
Hep-2 and Caco-2 cells. Mannose seems to be a cognate ligand for at least one of the adhesins 
expressed by this microorganism. However, mannose-independent adherence also has been 
reported (Mange et al., 2006).  Although operons coding for type 1 and curli fimbriae have been 
predicted (Lehnet et al., 2006; Zogaj et al., 2003), it has also been suggested that frimbrial 
structures are not involved in adherence under experimental conditions (Mange et al., 2006).  
Rather, fibronectin-mediated binding was suggested as a nonspecific adherence mechanism of  E. 
sakazakii.  Interaction with fibronectin, a major glycoprotein component of the extracellular 
matrix of eukaryotic tissue, would bring the bacteria closer to the epithelial cells  facilitating a  
specific interaction between bacterial ligands and host receptors (Mohan-Nair and 
Venkitanarayanan, 2007). 
 
2.3. Ways to prevent bacterial adherence 
Since adherence is a prerequisite to initiate colonization and infection, preventing 
bacterial adhesion would appear to be an ideal strategy for reducing infectious disease.  Several 
approaches have been evaluated, with each showing different levels of success and feasibility.  
These methods have involved both industrial and biomedical applications and are based on the 
following interactions: (i) changing surface interactions by coating inert surfaces with inhibitory 
macromolecules; (ii) metal chelators that interfere with bacterial growth, attachment and biofilm 
formation; (iii) prevention of adhesin biosynthesis; (iv) anti-adhesive vaccines; and (v) adhesion 
inhibition with receptor analogs.  The latter three will be covered in more detail.  
9 
 
2.3.1. Interference of adhesins biosynthesis 
This strategy is based on the inhibition of fimbriae biosynthesis by specific chemical 
agents.  The biosynthesis of fimbriae involves a helper protein that assists the assembly of large 
heterolymeric organelles. The best characterized fimbriae group, assembled via the chaperone-
usher-dependent pathway,  is synthesized by the action of an usher placed in the outer membrane.  
A periplasmic chaperone assists the usher by positioning structural components to the outer 
membrane (Klemm et al. 2010; Waksman and Hultgren 2009).  This chaperone-usher dependent 
pathway has been successfully disrupted by chemical interference at the assembly level of the 
fimbriae biogenesis (Pinker et al., 2006). In this study, a class of bi-cyclic 2-pyridones, called 
pilicides, were used to inhibit fimbriae synthesis.  Adherence of either type I or P type fimbriae to 
bladder cells and subsequent biofilm formation were reduced by approximately 90% in different 
E. coli strains.  The authors suggested that pilicides could be designed to target conserved regions 
on other chaperones and ushers, which would make it possible to interrupt the assembly of a 
range of different fimbriae (Åberg and Almqvist 2007; Larsson et al. 2005; Pinkner et al. 2006; 
Svensson et al. 2001). 
 
2.3.2. Anti-adhesive vaccines 
Inhibition of bacterial adhesion can also be achieved by immunization with the adhesin. 
The immunization would block the adhesion-receptor interaction by inducing the production of 
adhesin-specific antibodies in the host.  For most of the attempts done to make anti-fimbriae 
vaccines, the major structural proteins of the fimbriae were the targets of the immune response. 
However this approach has failed due to the constant sequence variation of these proteins. In 
contrast, in cases where the immune response is directed against the adhesin itself (i.e., the 
component that interacts with the host receptor), the results have been more successful.  For 
example, the vaccine for piglets based on K88 fimbriae from ETEC strains decreased the 
incidence of diarrhea (Rutter and Jones 1973).  Nevertheless, some vaccines targeting specific 
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adhesins were less successful.  For instance, although vaccination against FimH reduced UPEC 
infection of the blader of tested animals (Langermann et al. 1997, 2000, 2003), it did not prevent 
UPEC infection in humans.  FimH trigger a severe auto-immune disease, pauciimmune focal 
necrotizing glomerulonephritis. It is caused by the molecular mimicry between FimH and the 
human LAMP-2 protein that is expressed by many human cell types (Kain et al. 2008). 
 
2.3.3. Inhibition with receptor analogs 
One of the major types of adhesin-receptor interactions is the binding of bacterial 
adhesins to the sugar moieties of glycoproteins or glycolipids.  The molecular structures of many 
of the target receptors, however, are still unknown and the techniques to elucidate the interactions 
between the active site of the adhesin and the sugar are complicated.  For those cases where the 
interactions have been studied, the information about the adhesins and their cognate ligands have 
been used to design and develop receptor mimetics or decoys.  For example, it is known that 
uroplakin IA and Ib (mannose-rich glycoproteins) are the primary physiological receptors in the 
urinary tract for FimH (Min et al. 2002; Zhou et al. 2001).  Furthermore, several proteins that 
contain one or more N-linked mannose structures can also been recognized by FimH. This type of 
fimbrial adhesion has been successfully blocked by a variety of natural and synthetic saccharides 
which also are able to inhibit biofilm formation (Bouckaert et al. 2005; Nagahori et al. 2002 
Schembri and Klemm 2001).  However, the low affinity of the receptor analogs has been a 
significant obstacle in developing carbohydrate based therapies. A solution that may overcome 
this limitation is to make suitable chemical transformations of the saccharide analogs. For 
instance alkyl-substituted mannosides have affinities for FimH in the nanomolar range 
(Bouckaert et al. 2005). 
  Another strategy to develop an effective blocking adhesion therapy is to use a mixture of 
active receptor analogs. A heterogenic blend of carbohydrates could block a greater variety of 
pathogens in a more efficient way since most bacteria use more than one adhesin or lectin to 
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adhere to host cells. Furthermore, individual lectins of pathogens are often able to bind more than 
one carbohydrate moiety. Therefore, the more diverse the decoys, the more effective will be the 
defense mechanism.  Milk oligosaccharides are good examples of a natural mixture that contains 
effective binding inhibitors.  They have shown to be efficient agents blocking bacterial, as well as 
viral adherence (Kunz, et al., 2000; Shah, 2000; Ruiz-Palacios et al., 2003; Morrow et al., 2005; 
Newburg et al., 2005; Bao et al., 2007).  It is suggested that the composition of human milk OS 
changes during lactation in response to needs of the neonate. These OS cannot be metabolized; 
therefore, OS are able to reach the colon where, among other functions, they act as receptor 
decoys and protect the infant from infections. Milk OS as pathogen binding inhibitors will be 
discussed in more detail in section 4.1.2.  
 
3. Lectins 
Lectins are a heterogeneous group of oligomeric proteins that have a common activity, 
but different sizes, structures, molecular organization, and active sites (Lis and Sharon, 1998).  
They are defined as “proteins of non-inmunoglobulin nature capable of specific recognition and 
reversible binding to carbohydrate moieties of complex carbohydrates without altering covalent 
structure of any of the recognized glycosyl ligands” (Kocourek & Horejsi, 1983).  Apart from 
complex carbohydrates, oligosaccharides, glycoproteins, and glycolipids, lectins can also bind to 
free monosaccharaides. In fact, lectins specificity is often determined by hemagglutinating 
experiments using simple carbohydrates as inhibition agents  
Typically, lectins are di- or polyvalent, with each molecule containing two or more 
carbohydrate linking sites.  This characteristic gives them the ability to agglutinate cells, as each 
reaction site is capable of binding two or more carbohydrates on the surface of different cells, 
bringing them together and causing their precipitation.  Lectins can also induce precipitation of 
polysaccharide or glycoprotein molecules in solution by forming cross-links between independent 
molecules. The sugar ligands for which the lectins are specific are able to inhibit both the 
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agglutination and precipitation reactions. Usually, hemagglutinating or erythrocyte agglutination 
are used for lectin detection and characterization.  
Lectins are found in most organisms, ranging from simple organisms such as viruses and 
bacteria, to complex organisms such as plants and animals.  Their binding specificity confer them 
the capability to serve as recognition molecules within a cell, between cells, or between 
organisms (Chrispeels and Raikhelb, 1991).  
 
3.1. Bacterial Lectins 
Lectins are the primary type of adhesin identified in bacteria (Ofek and Doyle, 1994; 
Sharon et al., 2000), and they therefore mediate the adhesion of the organisms to the host cell. 
Even though several different adhesins of pathogenic bacteria have been identified (Table 1), the 
interactions between the lectins and their carbohydrate receptors have not yet been studied in 
depth. The molecular basis of these interactions requires the use of complex techniques.  For 
example FimH and PapG adhesins of uropathogenic E. coli  and adhesin F17-G of 
enterotoxigenic E.coli were crystallized in order to elucidate their three dimensional structures 
and to understand their mode of interaction (Choudhury et al., 1999; Donson et al., 2001; Sung et 
al., 2001) 
In gram positive bacteria, lectins may be located on the peptide-glycan matrix or are 
extended beyond the cell wall from the cytoplasmic membrane (Ofek et al., 2003).  In gram 
negative bacteria, the lectins can be presented as amorphous or seemingly amorphous structures, 
as part of the fimbriae, or as other types of outers membrane components (Ofek and Doyle, 
1994).  
The classification of bacterial lectins is usually based on their sugar specificity. 
Specificity can be determined by inhibiting the adhesion to host cells or glycan arrays, using free 
carbohydrates, in competition experiments. To establish sugar specificity it is necessary to 
account for the primary sugar specificity as well as the fine sugar specificity. The primary sugar 
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specificity refers to the simplest saccharide structure that inhibits the lectin adhesion. The fine 
sugar specificity defines the structure of the most potent carbohydrate inhibitor (Ofek et al., 
2003).  Not only is the type of carbohydrate important in defining lectin specificity, it is also 
essential to consider the position within the saccharide at which the lectin recognizes the sugar.  
Most bacterial lectins recognize terminal sugar structures; however, some also are able to 
recognize internal sequences. For instance, the tip of adhesion PapG of P fimbriae recognizes 
internal Gal(a14)Gal sequences in glycolipids on host cell surfaces (Striker et al., 1995; 
Stromberg et al., 1990).  In the case of glycolipids, the lectin binding appears to be dependent on 
the linkage of fatty acids to the sugar moieties. Detailed analysis of the fine sugar specificities of 
lectin-bearing bacteria is an extremely useful tool to establish the suitable carbohydrates for the 
development of anti-adhesion therapy of microbial infections.  
 
3.2. Plant lectins 
Plant lectins were the first to be identified and therefore have been more extensively 
studied than microbial lectins.  Many theories about their function have been proposed, however, 
their biological role is still not well understood.  One proposed function is to enhance the 
symbiosis between the plant and nitrogen fixing bacteria (mainly rhizobia and leguminous 
plants).  Another proposed function is to defend the plant against phytopathogenic fungi and 
animal predators (Lis and Sharon, 1998).  For example, some lectins have strong insecticidal 
properties. Plant lectins have also received attention for causing a type of food poisoning. 
Specifically, raw or insufficiently cooked beans cause nausea followed by vomiting and diarrhea 
due to Phaseolus vulgaris agglutinin (PHA).  This lectin binds to intestinal cells and becomes 
endocytosed, leading to hyperplasia and hyperthrophy of the small intestine (Peumans and Van  
Damme 1995). 
Lectin specificity has been well studied and many of the ligands have been identified 
(Table 2). Although plant lectins certainly interact with monosaccharides, their affinity for simple 
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sugars is usually low when compared to more complex carbohydrate structures (Garcia-Pino et 
al., 2007; Mandal et al., 1994). Techniques that have been used to elucidate the lectin specificity 
include dot blot assays with multiple oligosaccharides (Baldwin et al., 2000; Matsui et al., 2001) 
and microarrays with either immobilized glycans or immobilized lectins (Blixt et al. 2004; Kuno 
et al., 2005).  Plant lectins have been classified according to their ability to agglutinate cells, their 
carbohydrate specificity, their carbohydrate-binding domains, and their evolutionary relationships 
with other proteins.  Based on recent genome/transcriptome analyses, plant lectins were classified 
into twelve distinct families of evolutionary and structurally related lectin domains. The 
carbohydrate-binding domains are named in alphabetical order: Agaricus bisporus agglutinin 
homologs, amaranthins, class V chitinase homologs, cyanovirin family, Euonymus europaeus 
agglutinin family, Galanthus nivalis agglutinin family, proteins with hevein domains, jacalins, 
proteins with a legume lectin domain, LysM domains and Nicotiana tabacum. Each lectin domain 
has its own characteristic overall fold with one or more carbohydrate-binding sites (Van Damme 
et al., 2008). 
Plant lectins have many direct and indirect applications in biomedicine and 
biotechnology. They are widely used as reagents for the study of glycoconjugates in solution and 
cells and also for cell characterization and separation.  For example, an important application of 
SBA is to purge human bone marrow cells from haploidentical donors for transplantation into 
children born with severe combined immune deficiency. This procedure has been effective in over 
75% of the children treated (Reisner et al., 1983).  Research on the lectins field is critical since 
the characterization of additional native lectins and the development of modified derivatives will 
lead to the discovery of novel applications for these proteins.  
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4. Milk as source of bioactive carbohydrates 
4.1. Colostrum and mature milk 
The composition of milk from bovine and other mammals progressively changes post 
parturition to meet the changing requirements of the neonate. The lacteal secretion during these 
first days of milking is called colostrum or “early milk”, the composition of which is quite 
different from “mature milk”.  In the specific case of bovine milk, colostrum is secreted during 
the first four days of lactation (Gopal et al., 2000).  After this period, milk enters a transitional 
stage in which the composition will continuously change until it reaches a constant composition 
corresponding to the mature milk profile. The function of milk in these first days is not only to 
satisfy the nutritional requirements of the newborn, but also to provide protection against 
infection while the infant’s immune system is still developing. In addition to normal nutrients 
such as proteins, carbohydrates, fats, vitamins and minerals, colostrum contains many other 
biologically active constituents.  These include growth factors, antimicrobial compounds, and 
immune-enhancing components. 
Colostrum differs from normal milk in several important ways.  First, it is significantly 
higher in fat, protein, vitamins, and immunoglobulins, and is lower in lactose (Table 3). These 
components (especially immunoglubulins) decline rapidly after the first day of milking. 
Therefore, contrary to milk, it is difficult to assume a “typical” composition profile for bovine 
colostrum. The composition and physical characteristics also vary greatly with individual breeds, 
feeding regimen, length of dry periods of cows, and time post parturition 
 
4.2. Bioactive colostrum components.  
Human milk contains several constituents that have biological activity, including 
oligosaccharides, glycolipids and glycoproteins, mucins and gangliosides. Some of these 
components are reported to protect the infant against pathogenic bacteria and other infectious 
agents.  For example, colostrum glycoproteins and glycolipids were protective against 
16 
 
enterotoxigenic E. coli (Newburg et al. 1990), and an inhibitory effect of components derived 
from the milk-fat globule membrane against rotavirus has also been demonstrated. The 
bioactivity of these fractions was attributed to lactoferrin (Superti et al., 1997, 2001) and/or 
mucinous proteins (Yolken et al., 1992; Kanamaru et al., 1999), including but not exclusively 
MUC1 (Kvistgaard et al., 2004). 
 
4.2.1. Milk oligosaccharides 
Most of the studies on the bioactive properties of milk have focused on the 
oligosaccharide fraction, in particular, those found in human milk.  Although oligosaccharides are 
also found in bovine milk, they are present at significantly lower concentrations.  Human milk 
contains 12-14 g/L, and human colostrum contains as much as 23g/L (Coppa et al., 1999; Boehm 
and Stahl 2007).  In contrast, the concentration of oligosaccharides in the milk of domestic 
mammals is 10 to 100 time less (Boehm and Stahl, 2003). In the specific case of bovine milk, 
oligosaccharides are present at a concentration between 0.7 and 1.2 g/L during the early lactation 
period (Veh et al., 1981; Tao et al. 2008),  decreasing to 0.1- 0.6 g/L for mature milk. In addition, 
the structural heterogeneity of human milk oligosaccharides (HMO) is much greater than 
oligosaccharides found in milk from bovines and other animals, a property that appears to have 
important implications (see below). 
 
4.2.1.1. Composition of milk oligosaccharides. Milk oligosaccharides consist of oligomers of 3 
to 15 monosaccharides covalently linked through glycosidic bonds (Figure 2).  Among the major 
monomers found in human milk oligosaccharides are D-glucose (Glc), D-galactose (Gal), L-
fucose (Fuc), N-acetylglucosamine (GlcNAc), and N-acetyl neuraminic acid (NeuAc) (Rivero-
Urgell and Santamaria-Orleans,2001; Boehm and Stahl, 2007).  In contrast, bovine milk contains 
N-glycolylneuraminic acid (NeuGc), but fucose, present in human milk, is generally absent in 
bovines.  The largest single OS species in bovine milk is a heptamer containing Glc, Gal, NeuGc 
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and GlcNA.  However, tri and tetrasaccharides account for the majority of the BMO, with sialyl-
lactose the most abundant.  Bovine milk OS are built with a disaccharide or trisaccharide core. 
The disaccharides lactose and lactosamine are the most common cores (Ninonuevo et al., 2006); 
whereas, the trisaccharide core, consisting of lactose linked to Galβ-(1-3) or β-(1-6), is either not 
present or at very low abundance.   
Overall, about 200 different OS species have been identified in human milk, compared 
with only 40 OS species in bovine milk.  Furthermore, the diversity of linear and branched 
oligosaccharide structures is more complex in human milk compared to those found in bovine 
milk.  In addition, the number of isomers in human milk exceeds the number of isomers in bovine 
milk (Tao et al., 2008).  In bovine colostrum, acidic anionic OS account for up to 70% of the total 
OS content, with sialyl-lactose as the most abundant.  The latter OS accounts for as much as 30% 
of total OS in bovine colostrum (Tao et al., 2009).  In contrast, acidic OS are minor components 
in human milk, representing less than 20% of the total OS in colostrum and mature milk. As 
noted above, a unique characteristic of bovine milk compared with human milk is the presence of 
NeuGc-containing OS.  Nevertheless, this OS is only present in bovine colostrum; it’s 
concentration decreases to undetectable levels in mature milk.  Bovine milk, however, does not 
contain fucose-containing OS, whereas 70% of the human milk OS are fucosylated. 
In the same way that OS concentrations change over time, the composition of bovine 
milk OS also varies within the different lactation stages.  Although the total amount of OS 
decreases continuously during the first days of lactation, (Figure 3) the concentration of total 
neutral OS increases with time.  For example, the concentration of the neutral oligosaccharide 
lacto-N-neotetraose [LNnT; Gal (β1-4) GlcNAc (β1-3) Gal(β1-4) Glc], increased slightly after 6 
days of lactation and decreased again once milk reaches the mature stage. The previous behavior 
of the neutral OS and the dramatic decrease of NeuAc linked OS resulted in a large change in the 
acidic/neutral OS proportion.  Anionic OS decreased from 73% to 53.7% after 6 days, while the 
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neutral OS concentration increased from 22% to 43% in the transition stage and remained 
relatively constant until milk reached the mature stage (Tao et al., 2009) (Figure 3b). 
 
4.2.1.2. Biological functions. There is now considerable interest in understanding the biological 
functions of milk OS.  Several possible biological activities have been suggested, based mostly on 
research using human milk OS.  In addition, non-milk OS that have structural similarities to the 
core molecules of HMO have also been studied.  The latter include the galactooligosaccharides 
(GOS), OS derived from lactose via transgalactosylation reactions.  Both the milk-derived and 
lactose-synthesized OS are known to have prebiotic activity, in that they specifically stimulate the 
growth of beneficial bacteria in the intestinal tract (LoCasio et al., 2007; Ward et al., 2007; 
Marcobal et al., 2010; Sela et al., 2011).  They also provide postnatal stimulation of the immune 
system (Eiwegger et al., 2004; Braunstein et al., 1997; Recigno et al., 2009), and enhance defense 
against bacterial and viral infections (Kunz, et al., 2000, Morrow et al., 2005; Newburg et al., 
2005; Bao et al., 2007). 
 
4.2.1.2.1. Prebiotic activity of milk OS. Recent studies have shown that mixtures of HMO 
promote the growth of several species of bifidobacteria. In particular, Bifidobacterium longum bv. 
infantis and Bifidobacterium bifidum have been shown to have higher ability to ferment HMO 
than other species (György et al.1954; LoCasio et al., 2007; Marcobal et al., 2010). Most of the 
HMO that promote growth of bifidobacteria are neutral glycans, however, it was recently 
reported that B. infantis can also metabolize acidic oligosaccharides (Sela et al., 2011). 
Based on in vitro assays, the protein and non-protein components in human milk and 
bovine milk have also been reported to promote growth of several bifidobacteria, including 
Bifidobacterium bifidum var pennsylvanicus, Bifidobacterium infantis, and Bifidobacterium breve 
(Petschow et al., 1990). This phenomenon is supported by in vivo studies in which breast-fed 
infants have a much higher percentage of Bifidobacterium bifidum than formula-fed infants. In 
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contrast, formula fed infants have relatively low numbers of bifidobacteria, and a more diverse 
microflora with and enterococci, bacteroides and clostridia predominating (Lankaputhra, 1997; 
Lankaputhra & Shah, 1998; Goldman, 2000).  Nevertheless, it has been found that HMO 
consumption is not exclusive to bifidobacteria species, as Bacteroides fragialis and Bacteroides 
vulgatus are evidently able to metabolize free glycans and reach moderate levels.  In contrast, 
Enterococcus, Streptococcus, Veillonella, Eubacterium, Clostridium, and Escherichia coli had no 
or very low growth showing that HMO promote the growth of selective beneficial bacteria (Ward 
et al., 2007).   
 
4.2.1.2.2. Milk oligosaccharides as pathogen adherence inhibitors. The virulence of most 
pathogenic microorganisms depends on their ability to adhere to the host’s epithelial surface. 
Adhesion related virulence molecules are often lectins, glycan-binding proteins which bind to 
oligosaccharides on the epithelial cell surface (Sharon N. 1996). Binding sites for microorganisms 
are abundant in the gut since the intestinal mucosa is one of the most heavily glycosylated tissues 
(Nagler-Anderson 2001). The principal targets for viruses and bacteria are the sialylated and 
fucosylated OS (Bohem & Moro, 2008.), which are the two types of OS present in mammalian 
milks. This suggests that milk oligosaccharides serve as decoys, blocking pathogen adhesion, and 
protecting the breastfed infant against infections (Newburg et al., 2005). In fact, HMO and the 
glycans present on different cell types are synthesized by common glycosyl- and 
fucosyltransferases. (Newburg, 2000; Erney et al., 2000) 
Milk OS are responsible for inhibiting the adherence of pathogens to epithelial cells 
(Table 5) (Kunz, et al., 2000, Morrow et al., 2005; Newburg et al., 2005; Bao et al., 2007) and 
blocking the toxic effects of bacterial toxins such E. coli heat-stable enterotoxin (Cravioto et al., 
1991; Schwertmann et al., 1999). Fucosylated OS fraction of human milk, specifically α1,2-
linked fucosylated glycans, protect against C. jejune, enterotoxigenic  E. coli, its stable toxin and 
major strains of cacilviruses by inhibiting binding to host cell receptors (Cravioto et al., 1991; 
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Cervantes et al. 1995; Shah, 2000; Ruiz-Palacios et al., 2003; Morrow et al., 2005). Furthermore, 
it has been demonstrated that the concentration of α1,2-linked fucosylated glycans in the mother’s 
milk is  inversely related to the incidence of diarrhea caused by Campylobacter,  the stable toxin 
of enterotoxigenic E. coli and cacilviruses (Ruiz-Palacios et al., 2003; Morrow et al.2004; 
Newburg et al. 2004; Morrow et al, 2005).  
Human milk OS showed a strong inhibitory capacity against ETEC and UPEC adhesion, 
processes in which sialic acid seems to play an important role. After native OS are desialylated 
the levels of inhibition decrease. Since pure sialic acid does not inhibit adherence, it is thought 
that the acid residue is involved in recognition and the neutral parts of the OS are responsible for 
the binding. Bovine milk OS are also shown to be quite good inhibitors of UPEC strains, and less 
effective against ETEC strains for which human milk OS are shown to be better binding 
inhibitors. (Martín-Sosa et al. 2002). Helicobacter pylori have been shown to be inhibited by 3’-
sialyllactose, 6’-sialyllactose and 6’-sialyllactosamine isolated from bovine milk to different 
extents, with 3’sialyllactose being the most active OS (Simon et al., 1997). Non enteric pathogens 
are also inhibited by human milk, for example Streptococcus pneumoniae is inhibited by 
sialylated oligosaccharides ending in NeuAca2-3(or 6)Galb1, and to a less extent by OS that 
terminate with lactosamine (Galb1-4GlcNAcb1) (Anderson et al., 1986; Barthelson et al. 1998).   
Native and enzyme-modified whey products are effective inhibitors of association and 
invasion of Salmonella Typhimurium, E. coli O157:H7 and Enterobacter sakazakii to human 
CaCo-2 cells. In particular whey products which were treated with porcine pancreatic lipase 
(PPL) were better inhibitors of association and invasion. Such increase in the inhibitory effect is 
thought to be the consequence of the presence of active peptides or free fatty acids that were 
latent within the untreated material (Halpin et al. 2010) Neither the invasion nor the adherence 
inhibitions is attributed to the milk OS, which could be due to the very low concentration of these 
compounds in this fraction. 
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 It has been suggested that the main role of anionic OS is to block the adhesion of 
pathogenic bacteria to the epithelial surface, whereas the neutral OS are responsible of the 
development of beneficial intestinal microbiota. The premise that supports this hypothesis is 
based on the newborn immune system development state and concentration of acidic OS in the 
different lactation stages. In the first days of life the newborn’s immune system is not well 
developed, therefore, the defense against pathogens has to be based on external factors. 
Consequently, sialylated milk OS which are in high concentration in colostrum would be 
responsible for blocking pathogens infections during this stage. After some time has elapsed, the 
immune system is well developed and it’s able to control microbial infections; by this time acidic 
OS concentration has decreased significantly, while some of the neutral OS concentration 
increase, suggesting that neutral OS feed selective colonic bacteria promoting the infant health. 
Although this hypothesis is consistent, it cannot be insured that acidic OS exclusively protect 
from pathogens and neutral OS feed selective bacteria. There is enough evidence that shows that 
several fucosylated OS inhibit microbial adhesion to epithelial cells and acidic OS can also be 
metabolized by a Bifidobacterium specie. Therefore, neither the anionic nor the neutral OS have 
an exclusive function. 
 
4.2.1.2.3. Other functions of milk OS. In the specific case of sialylated OS, it has been 
suggested that increased production of gangliosides (important components in the membrane 
receptors and cell surfaces of the nervous system), serve as a source of sialic acid for newborn 
infants. Although all mammals have the capacity to synthesize sialic acids, newborn infants 
typically incorporate exogenous sialic acids because of their immaturity and rapid growth. The 
development of the brain exceeds their capacity to produce it and, therefore diet is an important 
source for sialic acids (Tao et al. 2008).  It has been shown that sialic acid-containing 
oligosaccharides also reduce the adhesion of leukocytes to endothelial cells, an indicator of an 
immune regulatory effect of certain HMO (Kunz and Rudloff, 2008). Other immunodulatory 
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effects that have been proposed include the decrease of allergic reactions in the skin (Gruber et 
al., 2010) and stimulation of the production of cyokins in blood-borne immune cells (Eiwegger et 
al., 2004). Milk OS can also have a direct effect on the immune system; OS can be taken up by 
the dendritic cells (Braunstein et al., 1997) which will have many potential downstream effects 
derived from the many known immune-regulating functions of dendric cells (Recigno et al., 
2009).  
 
4.2.1.3. Extracting oligosaccharides from milk.  
Most of the functions attributed to milk oligosaccharides have been established using 
HMO.  However, for obvious reasons, human milk components are not food grade and their use 
in food systems would not be legal. Despite this restriction, there is still much interest in 
obtaining large amounts of human OS or human-like OS for food or pharmaceutical applications. 
Accordingly, several approaches have been considered, based on both in-vivo and in-vitro 
technologies. 
The first strategy relies on exploiting the the natural biosynthesis of milk OS in the 
mammary gland.  Although not all of the specific reactions are known, it is possible to synthesize 
HMO either in tissue culture models (Ackland et al, 2001), transgenic animals (Prieto et al., 
1995), or genetically engineered bacteria (Priem et al., 2002).  However, these methods are 
biochemically rather complicated and would also presumably require legal approval before they 
could be implemented as accepted processes for the production of human consumption products. 
A second approach for obtaining oligosaccharides from milk would be to identify animal 
species or breeds that produce milk with high levels of OS.  The most important variables to be 
taken into account would include composition, availability, production size, and price.  Some of 
the animals that have been considered for this purpose include elephants, goats and cows.  
Elephant milk OS, in particular, closely resemble human milk OS, with respect to composition.  
However, to our knowledge there are no commercial applications for milk from elephants.  Goat 
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milk is also a rich source of OS and also has  structural diversity that is greater than that of sheep 
and cow. Bovine milk has been considered as a suitable source of OS because it is produced in 
very high quantities, is easily accessible, and the oligosaccharide-containing byproducts (i.e., 
whey) have a very low price. Until a few years ago, most of the whey produced during cheese 
manufacture was simply discarded. Recently, industry interest in whey utilization has increased 
significantly, as it now used to enhance cheese yield or produce high value alternative products. 
During 2010, total United States cheese manufacture resulted in the production of 4.2 milion tons 
of whey (USDA, 2011).  Therefore, the harvesting of the bioactive oligosaccharide fraction could 
increase the value of whey.  
Finally, another potential source of OS is bovine colostrum, and the protein-free or 
colostrum whey fraction, in particular. Although the colostrum processing industry is not nearly 
as developed as for bovine mature milk, there is still a large amount of colostrum sub-products 
available for use as a source of OS and other milk bioactive compounds. Most of these colostrum 
products are marketed in Japan and the Far East.  Bovine colostrum is relatively cheap since dairy 
producers must keep milk free of colostrum to fulfill legal regulations. In addition, since the US 
currently prohibits colostrum products in human foods, the existing product demand (at least 
domestically) is relatively low, which keeps the price low as well.  Furthermore, the OS 
concentration is significantly higher than in mature milk, representing an additional advantage of 
colostrum whey. 
As mentioned before, a unique characteristic of bovine colostrum, in contrast with human 
milk, is the presence of NeuGc-linked OS.  Although it is not clear, it has been postulated that the 
consumption of NeuGc is associated with risk or incidence of disease. In effect, an excess of 
NeuGc intake provokes an immune response in adults (Varki, 2001). Since NeuGc is present to a 
wide extent in most mammalian cells, its absence in human cells has been explained as an 
evolutionary phenomenon. The lack of NeuGc might be a strategy to decrease susceptibility or 
create resistance against certain pathogens. Microbes that cause important diarrheal diseases in 
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farm animals have a strong preference for NeuGc and humans are thus immune to these 
infections (Lanne et al., 1995;Varki, 2001). It will be necessary to study the health implications of 
NeuGc-linked OS consumption and its interaction with human pathogens in order to determine 
whether the presence of NeuGc in bovine milk would be a problem for the use of colostrum as a 
source of OS. It is possible that the use of NeuGc in moderated doses is safe enough to inhibit 
pathogen binding in any significant level. 
 
4.2.1.4. Fractionation, separation, and analysis of milk OS 
Several physical and chemical processes have been used to separate biologically valuable 
OS compounds from milk.  These include chromatography, gel and capillary electrophoresis, 
elective precipitation and membrane technology. The only technique that has been efficiently 
implemented at a large scale is membrane separation using either nano or conventional platforms.  
The effectiveness of nanofiltration and reverse osmosis has been evaluated using human, goat and 
bovine milk or whey, showing satisfactory results. The permeate from cheese whey ultrafiltration 
was shown to be a rich source of milk OS with composition similar to those in human milk. In the 
particular case of the whey obtained in the production of Gorgonzola cheese, 115 different OS 
were identified, with 7 having the same composition as human milk OS. (Barile et al., 2009). To 
facilitate the separation of lactose and the OS, nanofiltration has also been combined with 
enzymatic treatment which enhances the separation by increasing the size difference between the 
contained sugars. (Sarney et al., 2000; Roth et al., 2001; De-Frees, 2002; Martinez-Ferez et al., 
2006; Barile et al., 2009). The other technologies have not been implemented in the industry due 
to high capital cost, low productivity and the high difficulty of operation. 
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5. Oligosaccharides potential separation technologies  
5.1. Nanofiltration 
There are four major membrane separation technologies used in bioprocessing.  These 
include nanofiltration (NF), microfiltration (MF), utrafiltration (UF) and reverse osmosis (RO).  
All of these separate particles in a fluid based on their size, shape, and charge, using pressure as 
the driving force. The different separation methods differ from each other in the pore size, the 
membrane material, and the pressure exerted over the membrane.  MF uses the biggest pore size 
followed by UF, NF and RO.  Membranes for NF have pore sizes less than 0.002 µm, which 
approximates a molecular weight cut-off between 100 and 1200 Daltons (Wisconsin center of 
dairy research, 2004).  While small components will pass through a NF membrane, components 
larger than the membrane cut-off, will be retained despite the driving force.  The charge of the 
molecules is also a determinant of the separation. Ions with the same charge as the membrane will 
be retained due to an electrostatic repulsion, whereas ions with opposite charge will pass through 
(Zhang, 1998). The feed material that is retained and eventually gets concentrated is called 
retentate and the portion that crosses the membrane is the permeate or the filtrate. 
Nanofiltration has a wide range of applications in different industrial settings, including 
the pharmaceutical, textile, chemical, agricultural, water production, and electronic and optical 
industries. The dairy industry was among the first users of nanofiltration, as it can be used to 
concentrate and fractionate liquid whey.  The various product streams include lactose, whey 
permeates, and bioactive oligosaccharides (Bird, 1996; Koyuncu et al., 1999; Sarney et al., 2000; 
Rektor and Vatai, 2004; Martinez-Ferez et al., 2006).  Other applications include the clarification 
and concentration of fruit juices (Warczok et at., 2004), the treatment of waste water from 
beverage production (Pietraszek, 2001) and the separation of oligosaccharides from carbohydrate 
mixtures where mono and disaccharides are present. The latter application is important because 
OS separation is complicated and many difficulties have been encountered when using other 
technologies. In addition, NF is attractive since it allows the processing of large amounts of 
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product. Successful separation of oligosaccharides includes the recovery of soy bean 
oligosaccharides from soybean whey wastewater (Rucka et al., 1996), human milk 
oligosaccharides from lactose (Sarney et al., 2000), concentration of OS from chicory roots 
(Kamada et al., 2002), and purification of enzymatically synthesized GOS from lactose 
feedstocks (Goulas 2002, 2003). 
 
5.2. Lactose crystallization 
Crystallization from solution is an important separation and purification process in a 
variety of industries. Compounds obtained by this process include proteins, sugars such as 
sucrose, fructose and lactose, catalysts, sodium chloride and other pharmaceutical components. 
Crystallization is a solid-liquid separation that relies on the formation of solid crystals that will 
precipitate out of solution. Since crystallization occurs only while the solution is supersaturated, it 
is necessary to control the relation between solubility and supersaturation to achieve an effective 
separation. Supersaturation can be achieved by cooling, evaporation or modification of the 
solvent. The beginning of the crystallization i.e. the start of crystals formation can be spontaneous 
or induced.  In practice, crystallization is induced by adding crystals of the substance of interest to 
the reactor; this process is known as seeding. It promotes crystal formation of the solute over the 
surface area of the preformed solids. 
Due to the mutarotational property of lactose, the behavior of this disaccharide is quite 
different from other common sugars.  In aqueous solution lactose, α and β isomers are in a 
reversible equilibrium known as mutarotation. In general, the α form of lactose is less soluble.  
Therefore, α lactose will be the first to crystallize out of a supersaturated solution. After the 
crystallization of α lactose has occurred, the molecules in suspension will mutarotate to restore 
the equilibrium. Mutarotation proceeds relatively fast at high temperatures, whereas it is very 
slow at temperatures closer to the freezing point.  Since the ideal conditions to promote 
mutarotation and crystallization are conflicting, crystallization needs to be performed as the 
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temperature decreases slowly.   In this way, the solution will be supersaturated during the entire 
process and the molecules will have enough time to restore the equilibrium.  
 
5.3. Affinity chromatography  
Chromatography is a widely used separation method applied in industry and laboratory 
processes. It is a very versatile approach in terms of the wide variety of materials, equipment and 
techniques that can be used.  The separation is based on the distribution of the sample (solute) 
between the mobile phase and a fixed or stationary phase (Nielsen, 2003). Affinity 
chromatography is the only chromatography method that is based on the specific interaction 
between a molecule in solution and the ligand immobilized in the stationary phase. This 
reversible interaction usually involves biological materials as the stationary phase, including 
antibodies, enzyme inhibitors and lectins. When the sample passes through the column, the 
solutes that are complementary to the immobilized ligand will bind to the stationary phase while 
the rest of the components will be eluted or pass through the column. The bound analyte is then 
eluted by changing the mobile phase to induce dissociation (Figure 4).  
The immobilized ligands can be general or specific. Specific ligands such as antibodies 
will bind only to their cognate ligand. In contrast, general ligands such as lectins will bind all 
carbohydrate moieties for which they have affinity (e.g. Ulex europaeus EUA-1 lectin will bind 
molecules containing fucose). The target molecule of the ligands in the stationary phase will 
determine the type of compounds that can be separated from the sample. Industrial applications of 
affinity chromatography include preparing recombinant proteins, diagnostic enzymes, 
monoclonal antibodies, and restriction nucleases, removing trace amounts of contaminants from 
therapeutic substances, and processing of human plasma (Clonis, 1987). A summary of available 
affinity media or stationary phase ligands is shown in table 6.  
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Figure 1. Representation of bacterial adhesion. A. lectin-carbohydrate interactions: A1. Bacterial 
lectin-host glycoprotein, A2. Bacterial lectin-host glycolipid, A3. Host lectin-bacterial LPS; B. 
Hydrophobin-protein interactions; C. protein-protein interactions. Adapted from Ofek et al. 2003. 
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Organism Carbohydrate Specificity Structure Target tissue 
C. jejuni Fucα2GalβGlcNAc GP Intestinal 
E. coli Type 1 Manα3Manα6Man GP Urinary 
P Galα4Gal GL Urinary 
S NeuAc (α2–3)Galβ3GalNAc GSL Neural 
CFA/1 NeuAc (α2–8)– GP Intestinal 
F1C GalNAcβ4Galβ GL Urinary 
F17 GlcNAc GP Urinary 
K1 GlcNAcβ4GlcNAc GP Endothelial 
K99 NeuAc(α2–3)Galβ4Glc GL Intestinal 
H. influenzae [NeuAc(α2–3)]0,1 GL Respiratory 
  Galβ4GlcNAcβ3Galβ4GlcNAc     
H. pylori NeuAc(α2–3)Galβ4GlcNAc GP Stomach 
  Fucα2Galβ3(Fucα4)Gal GP   
K. pneumoniae Man GP Respiratory 
N. gonorrhoea Galβ4Glc(NAc) GL  Genital 
N. meningitidis [NeuAc(α2–3)]0,1 GL Respiratory 
  Galβ4GlcNAcβ3Galβ4GlcNAc     
P. aeruginosa L-Fuc GP Respiratory 
  Galβ3Glc(NAc)β3Galβ4Glc GL   
S. typhimurium Man GP Intestinal 
S. pneumoniae [NeuAc(α2–3)]0,1 GL Respiratory 
  Galβ4GlcNAcβ3Galβ4GlcNAc     
S. suis Galα4Galβ4Glc GL Respiratory 
 
Table 1. Carbohydrates attachment sites for bacterial pathogens on animal tissues, Predominant 
carbohydrate form: glycolipid (GL), glycoprotein (GP), glycophingolipids (GSL). Adapted from 
Ernst and Magnani, 2009; Ofek et al., 2003 and Sharon 2006 
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Table 2 . Relevant plant lectins their origin and carbohydrate specificity. Rudiger and Gabius, 
2002; Lis and sharon, 1986 ;Iskratsch et al., 2009; Chen et al., 2008 
 
 
Monosaccharides Glycans (*example of high specificity)
Con A Man/Glc  containing α linked Man
Concanavalin A
*GlcNAcβ2Manα6(GlcNAcβ2Manα3)Manβ4Glc
NAc
WGA
GlcNAc (low 
affinity) 
Dimers , Trimers ,oligosaccharides and 
glycoproteins containing GlcNAc, NeuNAc
Wheat Germ Agglutinin *GlcNAcβ4GlcNAcβ4GlcNAcβ4GlcNAcβ4GlcN
PNA Gal Galβ3GalNAc
Peanut Agglutinin *Galb1,3GalNAc-Ser/Thr
RCA Gal oligosaccharides ending in Gal and NAcGal
Ricinus Communis Agglutinin I
β β ( β  
GlcNAcβ2Manα3)Manβ4GlcNAc
ECL Gal Galβ4GlcNAc
Erythrina Cristagalli Lectin *Gal(NAc)β4GlcNAc-R
EEL Galα3Gal
Euonymus Europaeus Lectin *Galα3(Fucα2)Galβ3/4GlcNAc 
SBA GalNAc/ Gal
Oligosaccharides with terminal α- or β-linked 
NAcGal/ Gal residues
Soybean Agglutinin 
UEA 1 Fu *Fucα6GlcNAc
Ulex Europaeus Agglutinin I
DBA GalNAc α linked NAcGal
Dolichos Biflorus Agglutinin *GalNAcα3GalNAcα3Galβ4Galβ4Glc
PHA-E - Na2 and bisecting GlcNAc
*Galβ4GlcNAcβ2Manα6
 GlcNAcβ4                             Manβ4-R
 GlcNAcβ2Manα3
PHA-L - Tetraantenary complex oligosaccharides
*Galβ4GlcNAcβ2Manα6(GlcNAcβ2Manα3)(GlcN
Acβ4)Manβ4GlcNAc
 Galβ4GlcNAcβ2              Man
 Galβ4GlcNAcβ6
Phaseolus Vulgaris
Phaseolus Vulgaris 
Leucoagglutinin
Lectin
Phaseolus Vulgaris 
Erythroagglutinin
Canavalia ensiformis
Arachis hypogaea
Dolichos biflorus
Ulex europaeus I
Glycine max 
Phaseolus Vulgaris
Carbohydrate specificity
Ricinus communis 
(Euphorbiaceae)
Triticum vulgare
(Gramineae) 
Euonymus europaeus 
(Celastraceae) 
Erythrina cristagalli
-
Plant Specie
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Item 
Day of lactation Milk 
1 2 3 4  
Specific gravity 1.056 1.040 1.035 1.033 1.032 
Solids, % 23.9 17.9 14.1 13.9 12.9 
Protein, % 14.0 8.4 5.1 4.2 3.1 
Casein, % 4.8 4.3 3.8 3.2 2.5 
IgG, mg/mi 48.0 25.0 15.0 - 0.6 
Fat, % 6.7 5.4 3.9 4.4 3.7 
Lactose, % 2.7 3.9 4.4 4.6 5.0 
Vitamin A, ug/L 2950 1900 1130 760 340 
Vitamin D, IU/g fat 0.9 to 1.8  0.4 
Riboflavin, ug/mI 4.8 2.7 1.9 1.8 1.5 
Choline, mg/ml 0.70 0.34 0.23 0.19 0.13 
 
Table 3. Composition of colostrum and mature milk (Foley and Otterby, 1978) 
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Figure 2. Structures of human and bovine milk oligosaccharides.  Galactose   , Glucose   , 
GlcNAc    , NeuAc    , Fucose    . The HMO structures can be enlogated by repeating 
units of lactosamine (GlcNAc and galactose) and further decorated by sialic acid and fucose. The 
BMO structures can be further enlogated with residues of GlcNAc, galactose, and sialic acids. 
Adapted from Zivkovic and Barile, 2011. 
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 Human Milk Bovine Colostrum Bovine mature milk 
Concentration 7-12 g/L 0.7-1.2 g/L 0.1-0.6 g/L 
Structures 200 different OS 
30-40 OS structures 
Less complex with fewer isomers 
Type of OS 
High fucosylated 
(70% of the total 
OS) 
No fucosylated  OS No fucosylated  OS 
Neutral OS represent 
22% of the total OS 
Over 45% of the total OS 
are neutral 
   
Anionic OS are 
minor components 
(<20%) 
Over 70% of the total OS 
are acidic 
Acidic OS account for up 
to 50% 
NeuAc-linked OS NeuAc -linked OS (73%) NeuAc-linked OS 
 NeuGc-linked OS (5%)  
 
Table 4. Difference in concentration and composition of human milk, bovine colostrum and 
bovine mature milk  oligosaccharides. 
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a.         b. 
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Figure 3. a. Changes in the total oligosaccharides (OS) and total anionic OS of bovine milk at 
different stages of lactation [colostrum, transitional (day 6) and mature milk (day 120)]. RT = 
retention time. b. Changes in neutral and anionic OS proportions at different stages of lactation. 
Adapted from Tao et al. 2009 
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Oligosaccharide Pathogen 
Oligosaccharides Streptococcus pneumoniae 
Enterophathogenic E. coli 
Urophathogenic E. coli 
Enterotoxigenic E. coli 
Listeria monocytogenes 
Fucosylated 
oligosaccharides 
Campylobacter jejuni 
Vibrio cholerae 
Stable toxin 
sialylated 
oligosaccharides  
Streptococcus pneumoniae  
Sialyllactose Cholera toxin 
E coli 
P. aerugenosa 
Aspergillus fumigatus conidia 
Influeza virus 
Polyomavirus 
Helycobacter pylory 
 
 
Table 5. Pathogens inhibited by human milk oligosaccharides (Newburg et al., 2005; 
Chicholwski et al., 2011) 
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Figure 4. Principle of bioselective affinity chromatography. a. the support presents the 
immobilized ligand to the analyte to be isolated. b. Only the analyte makes contact with the 
ligand and attaches to it. C. The analyte is recovered by the introduction of and eluent, which 
dissociates the complex holding the analyte to the ligand. (Adapted from Nielsen, 2003) 
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Target molecules Potential Application 
Activated / 
Functionalized 
Functional spacer; support matrix; eliminates handling of toxic 
reagents 
Amino Acid Serum proteins; proteins; peptides; enzymes; rRNA; dsDNA 
Avidin Biotin 
Purification of biotin/avidin & derivatives; biotinylated substances. 
Biotin derivatives dissociate under nondenaturing conditions. 
Carbohydrate Binding Solube glycoproteins ; other carbohydrate-containing substances 
Carbohydrate 
Glycoproteins; lectins; other carbohydrate metabolite proteins. Proper 
selection can ensure one-step purification. 
Dye Ligand 
Nonspecific interaction. Mimic biological substrates (substrates, 
cofactors, effetors); proteins. Optimize purification protocol with 
different dyes 
Glutathione Purification of glutathione enzymes and GST tagged recombinant 
proteins 
Heparin General affinity ligand, useful for plasma coagulation proteins, nucleic 
acid enzymes, lipases, etc. 
Hydrophobic 
Interactions 
Couple ligands containing free carboxyl groups; proteins 
IMAC Immobilized Metal Affinity Chromatography. Uses interactions 
between protein and chelated metal to separate. 
Immunoaffinity Quantitative determinination of antigens, high specificity 
Nucleotide / 
Coenzyme 
Dehydrogenases; kinases; transaminases. Reliable adsorbents. 
Nucleic Acid mRNA; DNA; rRNA; other nucleic acids and oligonucleotides 
Protein A / Protein G Purification of immunoglobulins 
 
Table 6. Potential applications of affinity chromatography based on the stationary phase target 
molecules. Adapted from Sigma Aldrich, 2011 
 
 
 
 
38 
 
References 
Aberg, V., and F. Almqvist. 2007. Pilicides-small molecules targeting bacterial virulence. 
Organic & biomolecular chemistry 5:1827-34. 
Ackland, M. L., a Michalczyk, and R. H. Whitehead. 2001. PMC42, a novel model for the 
differentiated human breast. Experimental cell research 263:14-22. 
Aldrich, S. 2011. Sigma-Aldrich. Affinity Chromatography. 
Andersson, B., O. Porras, L. A. Hanson, T. Lagergard, and C. Svanborg-Edén. 1986. 
Inhibition Attachment of Streptococcus pneumoniae and Haemophilus influenzae by Human 
Milk and Receptor Oligosaccharides.pdf. The Journal of Infectious Disesases 153:232-237. 
Baldwin, C. I., J. E. Calvert, D. V. Renouf, C. Kwok, and E. F. Hounsell. 2000. Analysis of 
pigeon intestinal mucin allergens using a novel dot blot assay. Carbohydrate research 326:43-9. 
Bao, Y., L. Zhu, and D. S. Newburg. 2007. Simultaneous quantification of 
sialyloligosaccharides from human milk by capillary electrophoresis. Analytical biochemistry 
370:206-14. 
Barile, D., N. Tao, C. B. Lebrilla, J. Coisson, M. Arlorio, and J. B. German. 2009. Permeate 
from Cheese Whey Ultrafiltration is a Source of Milk Oligosaccharides. International Dairy 
Journal 19:524-530. 
Barthelson, R., a Mobasseri, D. Zopf, and P. Simon. 1998. Adherence of Streptococcus 
pneumoniae to respiratory epithelial cells is inhibited by sialylated oligosaccharides. Infection 
and immunity 66:1439-44. 
Benz, I., and M. A. Schmidt. 1992. AIDA-I, the adhesin involved in diffuse adherence of the 
diarrhoeagenic Escherichia coli strain 2787 (O126:H27), is synthesized via a precursor 
molecule. Molecular Microbiology 6:1539–1546. 
Bird, J. 1996. The application of membrane systems in the dairy industry. Journal of Dairy 
Science 49:16-23. 
Blixt, O., S. Head, T. Mondala, C. Scanlan, M. E. Huflejt, R. Alvarez, M. C. Bryan, F. 
Fazio, D. Calarese, J. Stevens, N. Razi, D. J. Stevens, J. J. Skehel, I. van Die, D. R. Burton, 
I. a Wilson, R. Cummings, N. Bovin, C.-H. Wong, and J. C. Paulson. 2004. Printed covalent 
glycan array for ligand profiling of diverse glycan binding proteins. Proceedings of the National 
Academy of Sciences of the United States of America 101:17033-8. 
Blomberg, L., H. C. Krivan, P. S. Cohen, and P. L. Conway. 1993. Piglet ileal mucus 
contains protein and glycolipid (galactosylceramdie) receptors specific for Escherichia coli K88 
fimbriae. Infection and Immunity 61:2526-2531. 
Boehm, G., and B. Stahl. 2003. Oligosaccharides, p. . In T. Mattila-Sandholm (ed.), Functional 
dairy products. Woodhead Publishers, Cambrige. 
39 
 
Boehm, G., and G. Moro. 2008. Structural and functional aspects of prebiotics used in infant 
nutrition. The Journal of nutrition 138:1818S-1828S. 
Bouckaert, J., J. Berglund, M. Schembri, E. De Genst, L. Cools, M. Wuhrer, C.-S. Hung, 
J. Pinkner, R. Slättegård, A. Zavialov, D. Choudhury, S. Langermann, S. J. Hultgren, L. 
Wyns, P. Klemm, S. Oscarson, S. D. Knight, and H. De Greve. 2005. Receptor binding 
studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. 
Molecular microbiology 55:441-55. 
Braunstein, J., L. Qiao, F. Autschbach, G. Schürmann, and S. Meuer. 1997. T cells of the 
human intestinal lamina propria are high producers of interleukin-10. GUT 41:215-20. 
Busscher, H. J., and A. H. Weerkamp. 1987. Specific and non-specific interactions in 
bacterial adhesion to solid substrata. FEMS Microbiology Reviews 46:165-173. 
Bäumler, A. J., and F. Heffron. 1995. Identification and sequence analysis of lpfABCDE, a 
putative fimbrial operon of Salmonella typhimurium. J. Bacteriol 177:2087-2097. 
Cervantes, L. E., and D. S. Newburg. 1995. α (1-2) Fucosylated chains (H-2 and Lewisb) are 
the main human milk receptor analogs for Campylobacter. Pediatric Research 37:171. 
Chen, P., Y. Liu, X. Kang, L. Sun, P. Yang, and Z. Tang. 2008. Identification of N-glycan of 
alpha-fetoprotein by lectin affinity microarray. Journal of cancer research and clinical oncology 
134:851-60. 
Chichlowski, M., J. B. German, C. B. Lebrilla, and D. A. Mills. 2011. The Influence of Milk 
Oligosaccharides on Microbiota of Infants : Opportunities for Formulas. Review Literature And 
Arts Of The Americas. 
Choudhury, D., a Thompson, V. Stojanoff, S. Langermann, J. Pinkner, S. J. Hultgren, and 
S. D. Knight. 1999. X-ray structure of the FimC-FimH chaperone-adhesin complex from 
uropathogenic Escherichia coli. Science (New York, N.Y.) 285:1061-6. 
Chrispeels, M. J., and N. V. Raikhel. 1991. Lectins, lectin genes, and their role in plant 
defense. The Plant cell 3:1-9. 
Clegg, S., B. K. Purcell, and J. Pruckler. 1987. Characterization of genes encoding type 1 
fimbriae of Klebsiella pneumoniae, Salmonella typhimurium, and Serratia marcescens. 
Infection and immunity 55:281-7. 
Clonis, Y. D. 1987. Large-scale affinity chromatography.pdf. Biotechnology. Biotechnology 
5:1290-1292. 
Collinson, S. K., S. C. Clouthier, J. L. Doran, P. A. Banser, and W. W. Kay. 1996. 
Salmonella enteritidis agfBAC operon encoding thin, aggregative fimbriae. Journal of 
Bacteriology 178:662-667. 
Connell, H., M. Hedlund, W. Agace, and C. Svanborg. 1997. Bacterial Attachment To Uro-
Epithelial Cells: Mechanisms and Consequences. Advances in Dental Research 11:50-58. 
40 
 
Coppa, G. V., P. Pierani, L. Zampini, I. Carloni, a Carlucci, and O. Gabrielli. 1999. 
Oligosaccharides in human milk during different phases of lactation. Acta paediatrica (Oslo, 
Norway : 1992). Supplement 88:89-94. 
Cravioto, a, a Tello, H. Villafán, J. Ruiz, S. del Vedovo, and J. R. Neeser. 1991. Inhibition 
of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin 
and oligosaccharide fractions of human colostrum and breast milk. The Journal of infectious 
diseases 163:1247-55. 
Dodson, K. W., J. S. Pinkner, T. Rose, G. Magnusson, S. J. Hultgren, and G. Waksman. 
2001. Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human 
kidney receptor. Cell 105:733-43. 
Echeverria, P., J. Seriwatana, D. N. Taylor, S. Changchawalit, C. J. Smyth, J. Twohig, and 
B. Rowe. 1986. Plasmids coding for colonization factor antigens I and II, heat-labile 
enterotoxin, and heat-stable enterotoxin A2 in Escherichia coli. Infection and immunity 51:626-
30. 
Eiwegger, T., B. Stahl, J. Schmitt, G. Boehm, M. Gerstmayr, J. Pichler, E. Dehlink, C. 
Loibichler, R. Urbanek, and Z. Szépfalusi. 2004. Human milk--derived oligosaccharides and 
plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. 
Pediatric research 56:536-40. 
Erdem, A. L., F. Avelino, J. Xicohtencatl-Cortes, and J. a Girón. 2007. Host protein binding 
and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli. 
Journal of bacteriology 189:7426-35. 
Erickson, a K., D. R. Baker, B. T. Bosworth, T. a Casey, D. a Benfield, and D. H. Francis. 
1994. Characterization of porcine intestinal receptors for the K88ac fimbrial adhesin of 
Escherichia coli as mucin-type sialoglycoproteins. Infection and immunity 62:5404-10. 
Erney, R., W. T. Malone, M. B. Skelding, A. A. Marcon, K. M. Kleman-Leyer, M. L. 
O’Ryan, G. Ruiz-Palacios, M. D. Hilty, L. K. Pickering, and P. A. Prieto. 2000. Variability 
of Human Milk Neutral Oligosaccharides in a Diverse Population. Journal of Pediatric 
Gastroenterology & Nutrition 30:181-192. 
Ernst, B., and J. L. Magnani. 2009. From carbohydrate leads to glycomimetic drugs. Nature 
reviews. Drug discovery. Nature Publishing Group 8:661-77. 
Foster, T. J. 2004. The Staphylococcus aureus “ superbug ” Journal of Clinical Investigation. 
Friedrich, M. J., N. E. Kinsey, J. Vila, and R. J. Kadner. 1993. Nucleotide sequence of a 
13.9 kb segment of the 90 kb virulence plasmid of Salmonella typhimurium: the presence of 
fimbrial biosynthetic genes. Mol. Microbiol 8:543-558. 
Garcia-Pino, A., L. Buts, L. Wyns, A. Imberty, and R. Loris. 2007. How a plant lectin 
recognizes high mannose oligosaccharides. Plant physiology 144:1733-41. 
41 
 
Goldman, A. S. 2000. Symposium : Bioactivity in Milk and Bacterial Interactions in the 
Developing Immature Intestine Modulation of the Gastrointestinal Tract of Infants by Human 
Milk . Interfaces and Interactions . An Evolutionary Perspective 1. Growth (Lakeland) 426-431. 
Gopal, P. K., and H. S. Gill. 2000. Oligosaccharides and glycoconjugates in bovine milk and 
colostrum. The British journal of nutrition 84 Suppl 1:S69-74. 
Goulas, A. K., P. G. Kapasakalidis, H. R. Sinclair, R. A. Rastall, and A. S. Grandison. 
2002. Purification of oligosaccharides by nanofiltration. J. Membr. Sci. 209:321-335. 
Goulas, A. K., A. S. Grandison, and R. a Rastall. 2003. Fractionation of oligosaccharides by 
nanofiltration. Journal of the Science of Food and Agriculture 83:675-680. 
Grüber, C., M. van Stuijvenberg, F. Mosca, G. Moro, G. Chirico, C. P. Braegger, J. 
Riedler, G. Boehm, and U. Wahn. 2010. Reduced occurrence of early atopic dermatitis 
because of immunoactive prebiotics among low-atopy-risk infants. The Journal of allergy and 
clinical immunology 126:791-7. 
György, P., R. F. Norris, and C. Rose. 1954. Bifidus factor. I. A variant of Lactobacillus 
bifidus requiring a special growth factor. Archives of Biochemistry and Biophysics 48:193-201. 
Hahn, E., P. Wild, U. Hermanns, P. Sebbel, R. Glockshuber, M. Häner, N. Taschner, P. 
Burkhard, U. Aebi, and S. a Müller. 2002. Exploring the 3D Molecular Architecture of 
Escherichia coli Type 1 Pili. Journal of Molecular Biology 323:845-857. 
Halpin, R. M., D. B. Brady, E. D. O’Riordan, and M. O’Sullivan. 2010. Untreated and 
enzyme-modified bovine whey products reduce association of Salmonella Typhimurium, 
Escherichia coli O157:H7 and Cronobacter malonaticus (formerly Enterobacter sakazakii) to 
CaCo-2 cells. Journal of applied microbiology 108:406-15. 
Hasty, D. L., I. Ofek, and H. S. Courtney. 1992. Minireview: Multiple Adhesins of 
Streptococci. Infection and Immunity 60:2147-2152. 
Iskratsch, T., A. Braun, K. Paschinger, and I. B. H. Wilson. 2009. Specificity analysis of 
lectins and antibodies using remodeled glycoproteins. Analytical biochemistry. Elsevier Inc. 
386:133-46. 
Kain, R., M. Exner, R. Brandes, R. Ziebermayr, C. A. Alderson, A. Davidovits, I. Raab, R. 
Jahn, S. Spitzauer, G. Sunder-plassmann, M. Fukuda, P. Klemm, A. J. Rees, and D. 
Kerjaschki. 2009. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. 
Nat Med 14:1088-1096. 
Kamada, T., M. Nakajima, H. Nabetani, N. Saglam, and S. Iwamoto. 2002. Availability of 
membrane technology for purifying and concentrating oligosaccharides. European Food 
Research and Technology 214:435-440. 
Kanamaru, Y., M. Etoh, X.-G. Song, T. Mikogami, H. Hayasawa, T. Ebina, and N. 
Minamoto. 1999. A High-Mr Glycoprotein Fraction from Cow’s Milk Potent in Inhibiting 
42 
 
Replication of Human Rotavirus in Vitro. Bioscience, Biotechnology and Biochemistry 63:246-
249. 
Kenny, B., R. DeVinney, M. Stein, D. J. Reinscheid, E. a Frey, and B. B. Finlay. 1997. 
Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian 
cells. Cell 91:511-20. 
Klemm, P., and M. A. Schembri. 2000. Bacterial adhesins: function and structure. 
International Journal of Medical Microbiology 290:27-35. 
Klemm, P., V. Hancock, and M. a Schembri. 2007. Mellowing out: adaptation to 
commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infection and 
immunity 75:3688-95. 
Klemm, P., V. Roos, G. C. Ulett, C. Svanborg, and M. A. Schembri. 2006. Molecular 
Characterization of the Escherichia coli Asymptomatic Bacteriuria Strain 83972 : the Taming of 
a Pathogen. Infection and immunity 74:781-785. 
Klemm, P., R. M. Vejborg, and V. Hancock. 2010. Prevention of bacterial adhesion. Applied 
microbiology and biotechnology 88:451-9. 
Kocourek, J., and V. Horejsi. 1983. A note on the recent discussion on definition of the term 
“lectin”, p. 3-6. In W. BøgHansen, T. C. and Spengler, G. A., Eds., and D. Gruyter (eds.), 
Lectins: Biology, Biochemistry and Clinical Biochemistry. Berlin, Germany. 
Koyuncu, I., M. Turan, D. Topacik, and A. Ates. 1999. Application of low pressure 
nanofiltration membranes for the recovery and reuse of dairy industry effluents. Water Science 
And Technology 41:213-222. 
Kumar, C. G., and S. K. Anand. 1998. Significance of microbial biofilms in food industry: a 
review. International Journal of Food Microbiology 42:9-27. 
Kuno, A., N. Uchiyama, S. Koseki-kuno, Y. Ebe, S. Takashima, and M. Yamada. 2005. 
Evanescent-field fluorescence-assisted lectin microarray : a new strategy for glycan profiling. 
Nature Methods 2. 
Kunz, C., and S. Rudloff. 2008. Potential anti-inflammatory and anti-infectious effects of 
human milk oligosaccharides. Advances in experimental medicine and biology 606:455-65. 
Kunz, C., S. Rudloff, W. Baier, N. Klein, and S. Strobel. 2000. Oligosaccharides in human 
milk: structural, functional, and metabolic aspects. Annual review of nutrition 20:699-722. 
Kvistgaard, a S., L. T. Pallesen, C. F. Arias, S. López, T. E. Petersen, C. W. Heegaard, and 
J. T. Rasmussen. 2004. Inhibitory effects of human and bovine milk constituents on rotavirus 
infections. Journal of dairy science 87:4088-96. 
Langermann, S., and W. R. Ballou. 2003. Development of a recombinant FimCH vaccine for 
urinary tract infections. Advances in Experimental Medicine and Biology 539:635-648. 
43 
 
Langermann, S., R. Mollby, J. E. Burlein, S. R. Palaszynski, C. G. Auguste, A. DeFusco, 
R. Strouse, M. A. Schenerman, S. J. Hultgren, J. S. Pinkner, J. Winberg, L. Guldevall, M. 
Soderhall, K. Ishikawa, S. Normark, and S. Koenig. 2000. Vaccination with FimH adhesin 
protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia 
coli. J Infect Dis 181:774-778. 
Langermann, S., S. Palaszynski, M. Barnhart, G. Auguste, J. S. Pinkner, J. Burlein, P. 
Barren, S. Koenig, S. Leath, C. H. Jones, and S. J. Hultgren. 1997. Prevention of mucosal 
Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science (New York, 
N.Y.) 276:607-11. 
Lankaputhra, W. E. V. 1997. Viability and therapeutic properties of probiotic bacteria. 
Victoria University of Technology. 
Lankaputhraa, W. E. V., and N. P. Shah. 1998. Antimutagenic properties of probiotic 
bacteria and of organic acids. Mutation Research/Fundamental and Molecular Mechanisms of 
Mutagenesis 397:169-182. 
Lanne, B., L. Uggla, G. Stenhagen, and K.-anders Karlsson. 1995. Enhanced Binding of 
Enterotoxigenic Escherichia coli K99 to Amide Derivatives of the Receptor Ganglioside 
NeuGc-GM3. Biochemistry 34:1845- 1850. 
Larsson, A., S. M. C. Johansson, J. S. Pinkner, S. J. Hultgren, F. Almqvist, J. Kihlberg, 
and A. Linusson. 2005. Multivariate design, synthesis, and biological evaluation of peptide 
inhibitors of FimC/FimH protein-protein interactions in uropathogenic Escherichia coli. Journal 
of medicinal chemistry 48:935-45. 
Lehner, A., K. Riedel, T. Rattei, A. Ruepp, D. Frishman, P. Breeuwer, B. Diep, L. Eberl, 
and R. Stephan. 2006. Molecular characterization of the alpha-glucosidase activity in 
Enterobacter sakazakii reveals the presence of a putative gene cluster for palatinose metabolism. 
Systematic and applied microbiology 29:609-25. 
Lindahl, M., and T. Wadstrom. 1984. K99 surface haemagglutinin of enterotoxigenic E. coli 
recognize terminal Nacetylgalactosamine and sialic acid residues of glycophorin and othe 
rcomplex glycoconjugates. Veterinary Microbiology 9:249-257. 
Lis, H., and N. Sharon. 1998. Lectins: Carbohydrate-Specific Proteins That Mediate Cellular 
Recognition. Chemical reviews 98:637-674. 
LoCascio, R. G., M. R. Ninonuevo, S. L. Freeman, D. a Sela, R. Grimm, C. B. Lebrilla, D. 
a Mills, and J. B. German. 2007. Glycoprofiling of bifidobacterial consumption of human 
milk oligosaccharides demonstrates strain specific, preferential consumption of small chain 
glycans secreted in early human lactation. Journal of agricultural and food chemistry 55:8914-9. 
Mandal, D. K., N. Kishore, and C. F. Brewer. 1994. Thermodynamics of lectin-carbohydrate 
interactions. Titration microcalorimetry measurements of the binding of N-linked carbohydrates 
and ovalbumin to concanavalin A. Biochemistry 33:1149-56. 
44 
 
Mange, J.-P., R. Stephan, N. Borel, P. Wild, K. S. Kim, A. Pospischil, and A. Lehner. 2006. 
Adhesive properties of Enterobacter sakazakii to human epithelial and brain microvascular 
endothelial cells. BMC microbiology 6:58. 
Marcobal, A., M. Barboza, J. W. Froehlich, D. E. Block, J. B. German, C. B. Lebrilla, and 
D. a Mills. 2010. Consumption of human milk oligosaccharides by gut-related microbes. 
Journal of agricultural and food chemistry 58:5334-40. 
Martin-Sosa, S., M. J. Martin, and P. Hueso. 2002. The sialylated fraction of milk 
oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic 
Escherichia coli human strains. The Journal of nutrition 132:3067-3072. 
Martinez-Ferez, A., S. Rudloffb, A. Guadixa, C. A. Henkelb, G. Pohlentzc, J. J. Bozaa, E. 
M. Guadixa, and C. Kunz. 2006. Goats’ milk as a natural source of lactose-derived 
oligosaccharides: Isolation by membrane technology. International Dairy Journal 16:173-181. 
Matsui, T., J. Hamako, Y. Ozeki, and K. Titani. 2001. Comparative study of blood group-
recognizing lectins toward ABO blood group antigens on neoglycoproteins, glycoproteins and 
complex-type oligosaccharides. Biochimica et biophysica acta 1525:50-7. 
Mattila-Sandholm, T., and G. Wirtanen. 1992. Biofilm formation in the industry: a review. 
Food Reviews International 8:573-603. 
McCoy, J. J., and B. J. Mann. 1994. Minireview: Adherence and Cytotoxicity of Entamoeba 
histolytica How Lectins Let Parasites Stick Around. Microbiology 62:3045-3050. 
McDaniel, T. K., K. G. Jarvis, M. S. Donnenberg, and J. B. Kaper. 1995. A genetic locus of 
enterocyte effacement conserved among diverse enterobacterial pathogens. Proceedings of the 
National Academy of Sciences of the United States of America 92:1664-8. 
Milk, O. 2007. Oligosaccharides from Milk. Nutrition Research 847-849. 
Min, G., M. Stolz, G. Zhou, F. Liang, P. Sebbel, D. Stoffler, R. Glockshuber, T.-T. Sun, U. 
Aebi, and X.-P. Kong. 2002. Localization of uroplakin Ia, the urothelial receptor for bacterial 
adhesin FimH, on the six inner domains of the 16 nm urothelial plaque particle. Journal of 
molecular biology 317:697-706. 
Mohan Nair, M. K., and K. Venkitanarayanan. 2007. Role of bacterial OmpA and host 
cytoskeleton in the invasion of human intestinal epithelial cells by Enterobacter sakazakii. 
Pediatric research 62:664-9. 
Morrow, A. L., G. M. Ruiz-palacios, X. Jiang, and D. S. Newburg. 2005. Symposium : 
Innate Immunity and Human Milk Human-Milk Glycans That Inhibit Pathogen Binding Protect 
Breast-feeding Infants against Infectious Diarrhea 1 , 2. The Journal of nutrition 1304-1307. 
Nagahori, N., R. T. Lee, S.-I. Nishimura, D. Pagé, R. Roy, and Y. C. Lee. 2002. Inhibition of 
adhesion of type 1 fimbriated Escherichia coli to highly mannosylated ligands. Chembiochem : 
a European journal of chemical biology 3:836-44. 
45 
 
Nagler-Anderson, C. 2001. Man the barrier! Strategic defences in the intestinal mucosa. 
Nature reviews. Immunology 1:59-67. 
Nagy, B., and P. Z. Fekete. 1999. Review article Enterotoxigenic Escherichia coli ( ETEC ) in 
farm animals. Veterinary research. 
Nataro, J. P., and J. B. Kaper. 1998. Diarrheogenic Escherichia coli. Clinical Microbiology 
Reviews 11:142-201. 
Newburg, D. S., L. K. Pickering, R. H. McCluer, and T. G. Cleary. 1990. Fucosylated 
oligosaccharides of human milk protect suckling mice from heat-stabile enterotoxin of 
Escherichia coli. The Journal of infectious diseases 162:1075-80. 
Newburg, D. S. 2000. Are All Human Milks Created Equal? Variation in Human Milk 
Oligosaccharides. Journal of Pediatric Gastroenterology & Nutrition 30:131-133. 
Newburg, D. S., G. M. Ruiz-Palacios, M. Altaye, P. Chaturvedi, J. Meinzen-Derr, M. D. L. 
Guerrero, and A. L. Morrow. 2004. Innate protection conferred by fucosylated 
oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiology 14:253-63. 
Newburg, D. S., G. M. Ruiz-Palacios, and A. L. Morrow. 2005. Human milk glycans protect 
infants against enteric pathogens. Annual review of nutrition 25:37-58. 
Ninonuevo, M. R., Y. Park, H. Yin, J. Zhang, R. E. Ward, B. H. Clowers, J. B. German, S. 
L. Freeman, K. Killeen, R. Grimm, and C. B. Lebrilla. 2006. A strategy for annotating the 
human milk glycome. Journal of agricultural and food chemistry 54:7471-80. 
Odenbreit, S. 2005. Adherence properties of Helicobacter pylori: impact on pathogenesis and 
adaptation to the host. Journal of Medical Microbiology 295:317–324. 
Ofek, I., and R. J. Doyle. 1994. Bacterial Adhesion to Cell tissues. Champman and Hall, 
London. 
Ofek I, Hasty DL, D. J. 2003. Bacterial adhesion to animal cells and tissues. ASM Press, 
Washington, DC. 
Ofek, I., and N. Sharon. 1990. Adhesins as lectins: Specificity and role in infection. Current 
Topics in Microbiology and Immunology 151:91-114. 
Orskov, I., and F. Orskov. 1990. Serologic classification of fimbriae. Current Topics in 
Microbiology and Immunology 151:71-90. 
Pelayo, J. S., I. C. Scaletsky, M. Z. Pedroso, V. Sperandio, J. a Girón, G. Frankel, and L. 
R. Trabulsi. 1999. Virulence properties of atypical EPEC strains. Journal of medical 
microbiology 48:41-9. 
Peumans, W. J., and E. J. Van Damme. 1995. Lectins as plant defense proteins. Plant 
physiology 109:347-52. 
46 
 
Pietraszek, M. Nanofiltracja w uzdatnianiu wody i oczyszczaniu ścieków w przemyśle 
spoywczym. Techniki Membranowe dla Czystych Technologii 31-34. 
Pinkner, J. S., H. Remaut, F. Buelens, E. Miller, V. Aberg, N. Pemberton, M. Hedenström, 
A. Larsson, P. Seed, G. Waksman, S. J. Hultgren, and F. Almqvist. 2006. Rationally 
designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proceedings of 
the National Academy of Sciences of the United States of America 103:17897-902. 
Pizarro-Cerdá, J., and P. Cossart. 2006. Bacterial adhesion and entry into host cells. Cell 
124:715-27. 
Priem, B., M. Gilbert, W. W. Wakarchuk, A. Heyraud, and E. Samain. 2002. A new 
fermentation process allows large-scale production of human milk oligosaccharides by 
metabolically engineered bacteria. Glycobiology 12:235-40. 
Prieto, P. a, P. Mukerji, B. Kelder, R. Erney, D. Gonzalez, J. S. Yun, D. F. Smith, K. W. 
Moremen, C. Nardelli, and M. Pierce. 1995. Remodeling of mouse milk glycoconjugates by 
transgenic expression of a human glycosyltransferase. The Journal of biological chemistry 
270:29515-9. 
Reisner, Y., N. Kapoor, D. Kirkpatrick, M. S. Pollack, S. Cunningham-Rundles, B. 
Dupont, M. Z. Hodes, R. a Good, and R. J. O’Reilly. 1983. Transplantation for severe 
combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells 
fractionated by soybean agglutinin and sheep red blood cells. Blood 61:341-8. 
Rektor, A., and G. Vatai. 2004. Membrane filtration of Mozzarella whey. Desalination 
162:279-286. 
Rescigno, M., and A. D. Sabatino. 2009. Science in medicine Dendritic cells in intestinal 
homeostasis and disease. The Journal of clinical investigation 119:2441-2450. 
Rivero-Urgëll, M., and a Santamaría-Orleans. 2001. Oligosaccharides: application in infant 
food. Early human development 65 Suppl:S43-52. 
Roth, S. A., J. K. Weil, and M. Spade. 2001. Method of Filtration of a Dairy Stream. U.S. 
Patent US 6,288,222 B1. 
Rounds, M. A., and S. S. Nielsen. 2003. Basic Principles of Chromatography, p. 437-460. In 
S.S. Nielsen (ed.), Food AnalysisThird. New York. 
Rucka, M., G. Pozniak, B. Turkiewicz, and W. Trochimczuk. 1996. Ultrafiltration 
membranes from polysulfone/aminated polysulfone blends with protelytic activity. Enzyme 
Microb. Technol 18:477-481. 
Ruiz-Palacios, G. M., L. E. Cervantes, P. Ramos, B. Chavez-Munguia, and D. S. Newburg. 
2003. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), 
and fucosyloligosaccharides of human milk inhibit its binding and infection. The Journal of 
biological chemistry 278:14112-20. 
47 
 
Rutter, J. M., and G. W. Jones. 1973. Protection against enteric disease caused by Escherichia 
coli—a model for vaccination with a virulence determinant? Nature 242:531-532. 
Rüdiger, H., and H. J. Gabius. 2001. Plant lectins: occurrence, biochemistry, functions and 
applications. Glycoconjugate journal 18:589-613. 
Sarney, B. D., C. Hale, G. Frankel, and E. N. Vulfson. 2000. A novel approach to the 
recovery of biologically active oligosaccharides from milk using a combination of enzymatic 
treatment and nanofiltration. Biotechnology and bioengineering 69:461-467. 
Scaletsky, I. C., M. L. Silva, and L. R. Trabulsi. 1984. Distinctive patterns of adherence of 
enteropathogenic Escherichia coli to HeLa cells. Infection and immunity 45:534-6. 
Schembri, M. A., and P. Klemm. 2001. Biofilm Formation in a Hydrodynamic Environment 
by Novel FimH Variants and Ramifications for Virulence Biofilm Formation in a 
Hydrodynamic Environment by Novel FimH Variants and Ramifications for Virulence. 
Infection and Immunity 69. 
Schwertmann, A., H. Schroten, J. Hacker, and C. Kunz. 1999. S-Fimbriae From Escherichia 
coli Bind to Soluble Glycoproteins From Human Milk. Journal of Pediatric Gastroenterology & 
Nutrition 28:257-263. 
Sela, D. a, Y. Li, L. Lerno, S. Wu, A. M. Marcobal, J. B. German, X. Chen, C. B. Lebrilla, 
and D. a Mills. 2011. An infant-associated bacterial commensal utilizes breast milk 
sialyloligosaccharides. The Journal of biological chemistry 286:11909-18. 
Shah, N. P. 2000. Effects of milk-derived bioactives: an overview. The British journal of 
nutrition 84 Suppl 1:S3-10. 
Sharon, N. 1996. Carbohydrate-lectin interactions in infectious disease. Adv Exp Med Biol 
408:1-8. 
Sharon, N., and I. Ofek. 2000. Safe as mother’s milk carbohydrates as future anti-adhesion 
drugs for bacterial diseases. Glycoconjugates journal 17:659-664. 
Sharon, N. 2006. Carbohydrates as future anti-adhesion drugs for infectious diseases. 
Biochimica et biophysica acta 1760:527-37. 
Sherlock, O., M. A. Schembri, A. Reisner, and P. Klemm. 2004. Novel Roles for the AIDA 
Adhesin from Diarrheagenic Escherichia coli : Cell Aggregation and Biofilm Formation. 
Journal of Bacteriology 186:8058-8065. 
Sherlock, O., R. M. Vejborg, and P. Klemm. 2005. The TibA Adhesin / Invasin from 
Enterotoxigenic Escherichia coli Is Self Recognizing and Induces Bacterial Aggregation and 
Biofilm Formation. Infection and Immunity 73:1954-1963. 
Simon, P. M., P. L. Goode, A. Mobasseri, and D. Zopf. 1997. Inhibition of Helicobacter 
pylori binding to gastrointestinal epithelial cells by sialic Inhibition of Helicobacter pylori 
48 
 
Binding to Gastrointestinal Epithelial Cells by Sialic Acid-Containing Oligosaccharides. 
Infection and Immunity 65:750-757. 
Stromberg, N., B.-inger Marklund, B. Lund, A. Hamers, W. Gaastra, and K.-anders 
Karlsson. 2010. Host-specificity of uropathogenic Escherichia coli depends on differences in 
binding specificity to Gala 1 -4Gal-containing isoreceptors. The EMBO Journal 9:2001 -2010. 
Struker, R., U. Nilsson, A. Stonecipher, G. Magnusson, and J. Hultgren. 1995. Structural 
requirements for the glycolipid receptor for human uropathogenic Escherichia coli. Mol. 
Microbiol 16:1021-1029. 
Sung, M. a, K. Fleming, H. a Chen, and S. Matthews. 2001. The solution structure of PapGII 
from uropathogenic Escherichia coli and its recognition of glycolipid receptors. EMBO reports 
2:621-7. 
Superti, F., M. G. Ammendolia, P. Valenti, and L. Seganti. 1997. Antirotaviral activity of 
milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. 
Medical microbiology and immunology 186:83-91. 
Superti, F., R. Siciliano, B. Rega, F. Giansanti, P. Valenti, and G. Antonini. 2001. 
Involvement of bovine lactoferrin metal saturation, sialic acid and protein fragments in the 
inhibition of rotavirus infection. Biochimica et biophysica acta 1528:107-15. 
Svensson, a, a Larsson, H. Emtenäs, M. Hedenström, T. Fex, S. J. Hultgren, J. S. Pinkner, 
F. Almqvist, and J. Kihlberg. 2001. Design and evaluation of pilicides: potential novel 
antibacterial agents directed against uropathogenic Escherichia coli. Chembiochem  : a European 
journal of chemical biology 2:915-8. 
Tao, N., E. J. DePeters, S. Freeman, J. B. German, R. Grimm, and C. B. Lebrilla. 2008. 
Bovine milk glycome. Journal of dairy science. Elsevier 91:3768-78. 
Tao, N., E. J. DePeters, J. B. German, R. Grimm, and C. B. Lebrilla. 2009. Variations in 
bovine milk oligosaccharides during early and middle lactation stages analyzed by high-
performance liquid chromatography-chip/mass spectrometry. Journal of dairy science. Elsevier 
92:2991-3001. 
Trabulsi, L. R., R. Keller, and T. A. T. Gomes. 2002. Typical and Atypical Enteropathogenic 
Escherichia coli. Emerging Infectious Diseases 8:508-513. 
Turner, S. M., A. Scott-Tucker, L. M. Cooper, and I. R. Henderson. 2006. Weapons of 
mass destruction: virulence factors of the global killer enterotoxigenic Escherichia coli. FEMS 
microbiology letters 263:10-20. 
United States Department of Agriculture, (USDA). 2011. United States Dairy Cheese 
Production by Year. 
Van Damme, J. M., N. Lannoo, and W. J. Peumans. 2008. Plant Lectins. Advances in 
Botanical Research 48:107-209. 
49 
 
Varki, A. 2001. Loss of N-Glycolylneuraminic Acid in Humans : Mechanisms , Consequences , 
and Implications for. Yearbook of Physical Anthropology 69:54 - 69. 
Veh, R. W., J. C. Michalski, A. P. Corfield, M. Sander-Wewer, D. Gie, and R. Schauer. 
1981. New chromatographic system for the rapid analysis and preparation of colostrum 
sialyloligosaccharides. J. Chromatogr. 212:313-322. 
Velden, A. W. V., a J. Bäumler, R. M. Tsolis, and F. Heffron. 1998. Multiple fimbrial 
adhesins are required for full virulence of Salmonella typhimurium in mice. Infection and 
immunity 66:2803-8. 
Waksman, G., and S. J. Hultgren. 2009. Structural biology of the chaperone-usher pathway of 
pilus biogenesis. Nature reviews. Microbiology. Nature Publishing Group 7:765-74. 
Warczok, J. 2004. Concentration of apple and pear juices by nanofiltration at low pressures. 
Journal of Food Engineering 63:63-70. 
Ward, R. E., M. Niñonuevo, D. a Mills, C. B. Lebrilla, and J. B. German. 2007. In vitro 
fermentability of human milk oligosaccharides by several strains of bifidobacteria. Molecular 
nutrition & food research 51:1398-405. 
Wisconsin Center for Dairy Research. 2004. Membranes 101. Quick Guides-Dairy 
Ingredients Program. 
Yamamoto, T., and T. Yokota. 1983. Plasmids of enterotoxigenic Escherichia coli H10407: 
evidence for two heat-stable enterotoxin genes and a conjugal transfer system. Journal of 
bacteriology 153:1352-60. 
Yolken, R. H., J. a Peterson, S. L. Vonderfecht, E. T. Fouts, K. Midthun, and D. S. 
Newburg. 1992. Human milk mucin inhibits rotavirus replication and prevents experimental 
gastroenteritis. The Journal of clinical investigation 90:1984-91. 
Zhang, L. 1998. A continuous nanofiltration process for separation and purification of 
oligosaccharides. The Ohio State University. 
Zhou, G., W. J. Mo, P. Sebbel, G. Min, T. a Neubert, R. Glockshuber, X. R. Wu, T. T. 
Sun, and X. P. Kong. 2001. Uroplakin Ia is the urothelial receptor for uropathogenic 
Escherichia coli: evidence from in vitro FimH binding. Journal of cell science 114:4095-103. 
Zivkovic, A. M., and D. Barile. 2011. Bovine Milk as a Source of Functional Oligosaccharides 
for Improving Human Health 1 , 2. Advances in Nutrition 284-289. 
Zogaj, X., W. Bokranz, M. Nimtz, X. Zogaj, W. Bokranz, M. Nimtz, and U. Ro. 2003. 
Production of Cellulose and Curli Fimbriae by Members of the Family Enterobacteriaceae 
Isolated from the Human Gastrointestinal Tract Production of Cellulose and Curli Fimbriae by 
Members of the Family Enterobacteriaceae Isolated from the Human Gastrointe. Infection and 
Immunity. 
 
 
50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Inhibition of lectin adherence to tissue culture cells by prebiotic carbohydrates 
Maldonado-Gómez M.X.,  Fangman T., Pinto A., Rupnow J., Hutkins R 
 
 
 
 
 
 
 
 
 
 
 
 
 
51 
 
Abstract  
Prebiotic carbohydrates, in addition to their ability to influence the colonic microbiota, 
are also able to interfere with how pathogenic bacteria attach to the epithelial cells that line the 
intestinal tract. For Salmonella, Escherichia coli, and other enteric pathogens, adherence is a 
receptor-mediated event between bacterial adhesins and their complementary ligands located on 
the mucosal surface.  Some prebiotic carbohydrates are structurally similar to these ligands and 
inhibit lectin binding.  However, the mechanism for this inhibition is not well understood, in part 
because the receptor sites on the target cells have not been identified.  The goal of this research 
was to measure the effect of two prebiotic carbohydrates, galactooligosaccharide (GOS) and 
polydextrose (PDX), on the binding kinetics of lectins to epithelial tissue culture cells.  To 
measure adherence, fluorescent-labeled lectins (ConA, WGA, PNA, RCA and ECL) were added 
individually to cover slips containing HEp-2 tissue culture cells.  In some treatments, either the 
cognate ligand or a prebiotic was added; unbound reactants were removed by washing.  
Photographs were taken by fluorescence microscopy and the images were analyzed to quantify 
the spectral component.  All the lectins that were able to bind to the target cells were inhibited by 
nearly 100% in the presence of 1 mg/ml of the cognate ligands. When prebiotics were added (up 
to 100 mg/ml), inhibition of lectin binding also was observed, depending on the structural 
similarity between the prebiotic and the cognate ligands. In particular, GOS significantly 
inhibited attachment of all the lectins except for WGA. In contrast, PDX did not significantly 
inhibit attachment of the lectins (with the exception of WGA), suggesting that it is structurally 
dissimilar to the HEP-2 receptor sites.  The results from this research support the role of GOS as 
an anti-adherence agent and also suggest that the receptor sites located on the surface of epithelial 
HEp-2 cells are structurally similar to GOS. In conclusion, the proposed mechanism of bacterial 
binding inhibition caused by active oligosaccharides was confirmed. 
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Introduction  
Nearly all microbial pathogens need to adhere to the surface of the host tissue cells in 
order to cause infections.  Adherence provides the means by which the pathogen can resist 
environmental shear forces, initiate biofilm formation, and begin to colonize or invade host tissue. 
To accomplish adherence, Van der Waal’s forces, Coloumbic forces, and hydrophobic interactions 
bring the bacteria to a closer proximity and mediate a reversible bond.  A more permanent 
adhesion occurs when structures on the bacterial surface interact with complementary ligands on 
the mucosal surface. (Busscher & Weerkamp 1987;  Ofek et al. 2003). These bacterial structures 
are specialized components or appendages defined as adhesins. The adhesins-receptor interactions 
are highly stereospecific and determine tissue tropism of the pathogen.  Three types of adhesin-
receptor interactions of different chemical nature have been recognized: (1) recognition between a 
protein on the surface of the bacteria and a complementary protein on the mucosal surface; (2) 
binding between hydrophobins in both bacterial and tissue cell surfaces; and (3) binding of lectins 
with carbohydrate moieties. The latter is the most common mechanism and accounts for the 
primary means by which adherence occurs among bacterial pathogens. 
Lectins, which are also found in viruses, plants and animals, are proteins capable of 
specific recognition and reversible binding to carbohydrate moieties without altering the covalent 
structure of the glycosyl ligands. Typically, each lectin molecule contains two or more 
carbohydrate linking sites, and this di- or polyvalency enhances adherence activity.  In addition, 
many bacterial pathogens have the ability to express different adhesins and at different stages of 
infection.  Thus, it is the concerted action of the different adhesins that allows infections to occur 
(Klemm et al., 2010).  
Prebiotic carbohydrates are defined as food ingredients that provide beneficial effects for 
the host by selectively stimulating the growth and/or activity of one or a limited number of 
bacteria in the colon (Gibson et al., 1995).  In addition to their ability to influence the colonic 
microbiota, however, some prebiotics are also able to interfere with how pathogenic bacteria 
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attach to the epithelial cells that line the intestinal tract.  This adherence inhibitor property has 
also been attributed to several naturally-occurring carbohydrates, including milk 
oligosaccharides, mannan oligosaccharides, and pectic oligosaccharides (Kisiela et al. 2006; 
Ganan et al. 2010). It has been proposed that the bioactivity of such carbohydrates is due to their 
structural similarity to the glycans present on the surface of host cells. Hypothetically, these free 
carbohydrates would act as receptor analogs and block the lectin-carbohydrate interaction.  
Bacteria would recognize these molecules and bind to them instead of binding to the host cell 
receptor.  However, the mechanism of adherence inhibition is not well understood, in part because 
the receptor sites on the target cells have not been identified and because there are other variables 
that could also affect the adherence event. 
  To study and understand the mechanism of adherence inhibition of bioactive 
carbohydrates, we propose a simplified model in which tissue culture cells are exposed to plant 
lectins to simulate bacterial lectin-receptor interactions. The use of plant lectins eliminates some 
of the variables associated with the use of live pathogens used in anti-adherence experiments. 
Such variables include presence of multiple adhesins with different carbohydrate specificities, 
expression of adhesions depending on the growth stage and environmental conditions, and the 
bacterial production of interfering metabolites. In addition, lectins are well characterized and their 
cognate ligands are known, which allow us to test the possible mechanism of adhesion inhibition. 
Thus, lectin attachment would be inhibited in the presence of the cognate ligands or 
carbohydrates with similar structure.  Therefore, the goal of this research was to measure the 
effect of  the cognate ligands and two prebiotic carbohydrates, galactooligosaccharide (GOS) and 
polydextrose (PDX), on the binding kinetics of lectins to epithelial tissue culture cells.   
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Materials and Methods 
 
Monosacharides and prebiotics oligosaccharides. The monosacharides used in the present 
study include glucose, galactose, N-acetyl galactosamine, N-acetyl glucosamine (Sigma Chemical 
Co.,St. Lous, MO, USA) and mannose (Acros Organics, New Jersey, USA). Polydextrose (PDX) 
(Danisco) and galactooligosaccharide (GOS) were tested as potential inhibitors of lectin 
attachment. Two different GOS products were evaluated.  The GOS (F-GOS) from Friesland 
Campina (FrieslandCampina, New York, USA) contains 53% GOS, and the GOS (G-GOS) from 
GTC Nutrition (GTC Nutrition, Golden, CO) contained 92% GOS. 
 
Lectins. In total, nine fluorescein-labeled lectins were obtained (Vector Laboratories, Inc., CA, 
USA) and evaluated, including Concanavalin A (Con A), Wheat Germ Agglutinin (WGA), 
Peanut Agglutinin (PNA), Ricinus Communis Agglutinin I (RCA), Erythrina Cristagalli Lectin 
(ECL), Euonymus Europaeus Lectin (EEL), Soybean Agglutinin (SBA), Ulex Europaeus 
Agglutinin I (UEA I), and Dolichos Biflorus Agglutinin (DBA). Sources and carbohydrate 
specificity are summarized in table 1. 
 
Tissue culture conditions. HEp-2 cells were obtained from the American Type Culture 
Collection (Manassas, Virgina).  Cells were maintained under tissue culture conditions in 
minimal essential medium (MEM/EBSS NEAA Modified, HyClone, Thermo Fisher Scientific 
Inc, Utah, USA) supplemented with 10% fetal bovine serum (HyClone). For inhibition assays, 
subconfluent monolayers of HEp-2 cells were harvested with 0.25% (vol/vol) trypsin-EDTA 
solution (HyClone) and seeded into 24 well tissue culture plates at approximately 5 x 104 HEp-2 
cells per well. Plates were incubated under tissue culture conditions for 30 hours before the 
experiment. 
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Lectins adherence assessment.  Subconfluent HEp-2 cells were prepared as described above. 
Lectin solutions were prepared in MEM media without FBS (wMEM) and added at a 
concentration of 7 μg/ml into each well.  Cells were incubated at room temperature for 1 hour in 
the dark to preserve fluorescein fluorescence.  Preliminary studies revealed that 1 hour incubation 
time was sufficient to induce binding. Wells were then washed 2 times with wMEM and 3 times 
with PBS to remove un-bound lectin.  Coverslips were fixed with 10% formalyne for 15 min and 
washed with PBS.  Coverslips were placed in slides and analyzed microscopically (see below).  
All experiments were performed in duplicate. 
  
Competition experiments.  The same procedure described for the lectin adherence experiments 
was followed. However, for these competition experiments, 1 ml of the lectin-carbohydrate 
solution was added. Cognate ligands were added at concentrations of 1, 10 and 100 mg/ml and for 
oligosaccharides, concentrations of 25, 50 and 100 mg/ml were used 
 
Fluorescence microscopy. The samples were observed under an Olympus FV500 Confocal 
Laser Scanning Microscope with an Inverted Olympus IX81 microscope and a PlanApo 100X oil 
objective. The 488nm Argon laser was used for the fluorescein stained lectins (Vector 
Laboratories). For each sample, images from 10 different areas of the coverslip were taken.  Each 
picture contained approximately 50 cells. 
 
Image Analysis. MATLAB software (Version 7.8, 2007, The MathWorks, Inc., Natick, 
Massachusetts) was used to quantify the amount of green contained in each picture. The primary 
spectral component of green was obtained using the RGB color model. The programmed code 
separates the green channel from the image, and then adds all of the individual values obtained 
per pixel. Therefore, the total amount of green present in each picture was calculated.  
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Statistical analysis. Significant differences between the treatments were determined using one-
way ANOVA.  Post hoc pair-wise comparisons were done using Tukey’s test. Differences in 
lectins attachment were considered significant when P-values were less than 0.05.  GraphPad 
Prism 5 (version 5.03, GraphPad Software, Inc, 2010) was used to perform statistical tests . 
 
 
Results 
Attachment of lectins to HEp-2 cells.  Nine lectins were assessed for their ability to attach to 
HEp-2 cells. Only five of the tested lectins, Con A, ECL, PNA, RCA, and WGA, were able to 
attach to Hep-2 cells. In contrast, cells treated with DBA, SBA, UEA I and EEL lectins did not 
show any fluorescence signal when observed microscopically. 
 
Cognate ligands block lectins binding to tissue culture cells. All of the lectins that were able to 
bind to HEp-2 cells were inhibited by nearly 100% in the presence of 10 mg/l of at least one of 
the cognate ligands (Figure 2). Con A was the only lectin for which the presence of the cognate 
ligand did not inhibit binding (in fact, there was a significant increase in adherence; Figure 2c). 
The latter was observed when 1 mg/ml of mannose was added. However, using the same 
monosaccharide but at higher concentrations (i.e., 10 and 100 mg/ml), attachment was effectively 
inhibited by 42 and 98% respectively. When two different monosaccharaides were used as 
cognate ligands, different levels of inhibition were obtained (Figure 2a,c,e).  
 
Prebiotic oligosaccharides inhibit lectins attachment to HEp-2.  Prebiotic oligosaccharides 
were also able to reduce adherence of the lectins to HEp-2 cells (Figure 1 and 2). The 
concentrations used to test the oligosaccharides were higher than the cognate ligands since the 
affinity towards these carbohydrates was unknown and less affinity was expected.  However, both 
types of GOS were highly effective at inhibiting attachment. In fact, RCA, ECL and PNA binding 
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was completely inhibited by GOS even when the lowest concentration (25 mg/ml) was added 
(Figure 2a,b,e). GOS showed significant inhibition in most cases, and at least for one type of 
GOS a concentration of 100 mg/ml was enough to inhibit completely the lectin attachment. In 
general, G-GOS blocked lectin attachment more efficiently than F-GOS and PDX, with the 
exception of WGA. When HEp-2 cells were exposed to WGA, PDX was the only prebiotic 
carbohydrate capable of inhibiting attachment; neither G-GOS nor F-GOS had any significant 
effect. Nevertheless, PDX was not a very efficient inhibitor since 45% was the maximum level of 
inhibition reached by PDX for this lectin (Figure 2d).  The only case in which PDX blocked the 
lectin attachment in a substantial manner was in the Con A lectin competition assay. Indeed, 
higher inhibition of this lectin was obtained in presence of PDX than F-GOS (Figure2c).  
 
Discussion 
Plant lectins have been shown to be suitable reagents for characterizing carbohydrate 
moieties in epithelial cells and other biological systems.  In fact, micro arrays and flow cytometry 
using fluorescently-labeled lectins have been employed to analyze cell surface carbohydrates in 
several cell lines (Chen, et al. 2007; Alam et al. 1990).  In this study, plant derived lectins were 
used to elucidate the mechanism by which bacterial pathogens adhere in vitro to cell lines. The 
first step of this approach was to measure lectin attachment directly to HEp-2 cells, which 
provided a basis for predicting the ligand composition of these cells.  Subsequent competition 
experiments enabled us to assess how similar prebiotic carbohydrates were to these ligands. 
Carbohydrate content of the HEp-2 cell surface. The observation that several plant-
derived lectins, including Con A, ECL, PNA, RCA, and WGA, attach to the human larynx 
carcinoma cell line implies that the HEp-2 cell surface contains one or more carbohydrates 
moieties for which these lectins are specific.  Consequently, it can be inferred that these 
carbohydrates likely contain  glucose, galactose, α linked mannose, N-Acetyl glucosamine, 
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dimers or oligosaccharides containing N-Acetylglucosamine and/or glycans with the linkages 
galactose(β-1,3)N-Acetylgalactosamine or galactose (B1-4)N-Acetylglucosamine.  However, to 
our knowledge, the carbohydrate content of the HEp-2 cell surface has not been characterized. 
The adhesins of several pathogenic bacteria are well characterized and their carbohydrate 
specificity is known (Ohlsen et al., 2009).  For example, P-fimbriated uropathogenic E. coli 
strains that bind to HEp-2 cells (Guyer er al., 2002) contain an adhesin specific for 
glycosphingolipid containing Galα4gal (Ohlsen et al., 2009).  Other microorganisms that attach  
to HEp-2 cells include  S. thyhimurium ( McGowan et al. 2010, unpublish data), K. pneumoniae 
(Favre-Bonte et al., 1999) and E.coli Type 1 (Boudeau et al., 2001), all of which bind to mannose 
residues (Ohlsen et al., 2009; Ofek et al., 2003;  Stromberg et al., 1990).  In contrast, S. 
pneumonia which also attaches to HEp-2 cells, binds carbohydrates containing the linkages 
Gal(β-1,3)NAcGal and Gal (B1-4)NAcGlu, (Ohlsen et al., 2009;  Idanpaan-Heikkila et al., 1997; 
Pracht et al., 2005).  In consequence, if a pathogen is able to bind to Hep-2 cells it implies that the 
carbohydrate for which it is lectin is specific is present in the epithelial cell surface.    
 To assess the ability of prebiotics to act as bacterial adhesin inhibitors, competitive 
binding experiments were performed.  However, instead of using the bacterial adhesins, we used 
plant derived lectins for which the cognate receptors were already established.  
 Cognate ligands were added to test the hypothesis that lectin attachment to culture 
cells would decrease in the presence of free carbohydrates for which these proteins have high 
binding affinity.  Indeed, all of the cognate ligands were able to inhibit lectin attachment, 
confirming that lectins are able to bind to free carbohydrates, reducing the number of unbound 
lectins able to bind the epithelial cells receptors. 
 The extent of inhibition is an indicator of the binding affinity towards a particular 
monosaccharide. In other words, the sugar with the highest affinity towards a particular lectin will 
bind the protein the most; as a result, the attachment to HEp-2 cells will be inhibited more 
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efficiently by this sugar than by any other.  For example, RCA adherence was completely 
inhibited by galactose, whereas NAcGal showed no inhibition at the same concentration 
(1mg/ml). This behavior is consistent with the reported values of the binding affinity constants 
(KA) for different galactose and NAcGal containing sugars (Itakura et al., 2007; Houston and 
Dooley, 1982). For example p-Nitrophenyl glycosides of βGal and βGalNAc were shown to have 
a KA of approximately 1.8 x 105 and 0.3 x 105 M-1 , respectively (Itakura et al., 2007). In a similar 
way, the addition of galactose at the lowest concentration had no effect on ECL attachment, but it 
was effectively inhibited by NacGlc. According to Wu et al. (2007) galactose is a much better 
inhibitor than NAcGlc. The inconsistency may be related to the fact that the binding affinity for 
these monosaccharides was evaluated in terms of binding inhibition. In Wu et al., α1-acid 
glycoprotein was used as the target for ECL. Lectins could target different glycan moieties in 
each case, consequently galactose and NAcGlc exert different levels of inhibition. In the case that 
NAcGlc is present in low concentrations or not present at all in α1-acid glycoprotein, but HEp-2 
contain plenty of NAcGlc moieties and ECL is targeting for this monosaccharide, NAcGlc will 
act as an efficient inhibitor for HEp-2 and have little or no effect for α1-acid glycoprotein. 
Accordingly, monosaccharides had to be present in solution at different concentrations to achieve 
equivalent percentages of inhibition.  As revealed by ConA, mannose concentration must be 
increased by a factor of 10 to reach the same inhibition obtained using glucose. Contradictorily, 
other authors report that mannose in its pyranose form has a higher binding affinity for Con A 
than glucose has (Goldtein et al., 1965; Schwarz et al., 1993).  
 Binding affinity of the tested lectins towards prebiotic carbohydrates was unknown. 
Nevertheless, it was predicted that lectins attachment would be inhibited by prebiotic 
oligosaccharides, since their structural monosaccharides and their arrangement are similar to the 
cognate ligands in most of the cases. In fact, prebiotics were also capable of binding the lectins 
and reducing the adherence. In general, the greater the similarity between the prebiotic and the 
cognate ligands, the greater was the inhibition observed. For example, GOS was a more highly 
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efficient inhibitor for ECL, PNA and RCA lectins. The mentioned lectins are selective for 
galactose containing glycans and GOS molecules are comprised in the majority by galactose 
molecules. In contrast, PDX was a poor inhibitor or did not block the adherence at all, because it 
lacks galactose molecules in it structure (Figure 3). The reason why GTC GOS showed to be a 
better binding inhibitor among the GOS tested is the difference of the galactooligosaccharides 
concentration in each of the products.  G-GOS contains 90%, while F-GOS contains only 57% 
(Friesland Campina, GTC Nutrition).  
 Although PDX has the highest glucose content, G-GOS was shown to be a better 
inhibitor of Con A attachment. This phenomenon could be the result of the difference in the 
monomers distribution and OS structures of each of the prebiotics. Possibly, the branched 
structure of PDX causes steric hindrance, and makes difficult the access of the glucose molecules 
to the active site of the lectin, and therefore, diminishes its binding affinity. On the other hand, 
GOS are linear oligosaccharides of smaller sizes. GOS molecules would be able to reach the 
active site of the lectin more easily, inhibiting to a higher extent it adhesion to the target cells. In 
fact, the carbohydrate molecular size has been suggested as an explanation of the amylopectin 
precipitation failure only when large molecules are tested (Goldstein et al. 1965). 
 Interestingly PDX was able to inhibit WGA although it is not specific for either 
glucose or galactose containing sugars. The inhibition observed could be due to the presence of 
organic acid in the PDX mixture. Negative charged molecules might interfere in the lectin 
attachment to the target cell. Commercial PDX is synthesized using organic acids as catalyst; 
however some of the acids react and end up in the final product. Organic acid can be either 
attached to the molecules or free in the mixture. (Allingham 1982).  Agglutination of WGA has 
been inhibited by organic acids such NeuNAc and NeuNGc (Bhavanandan  and  Katlic, 1979). 
However, the affinities of acids are lower than other neutral cognate ligands and acid is present in 
PDX in trace amounts, what make this hypothesis unlikely. An alternative explanation could be a 
possible affinity towards specific linkages in the PDX polymers. Specificity could be more likely 
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towards the β 1-6 glycosidic linkage which is the PDX predominant bond. However WGA could 
also target any other of the possible glycosidic bonds. (Allingham 1982). Specificity for the type 
of linkages was also observed in ECL competition experiments. This is concluded based on the 
difference between the percentages of inhibition obtained with GOS and galactose. Although 
galactose significantly inhibited ELC attachment to HEp-2 cells, its action was not as effective as 
both types of GOS. The high effectiveness of the galactooligosaccharides may be attributed to the 
ECL affinity for the linkage Gal(b1-4)NAcGlu which is essentially the same conformation that 
Gal(b1-4)Glu (GOS glycosidic bond) has. This would imply that ECL has preference for glycans 
containing Gal(b1-4)NAcGlu over free galactose.   
 The only case in which the presence of a cognate ligand significantly increased the 
adherence of the lectin instead of inhibiting the attachment was ConA.  This situation was 
observed only when the lowest mannose concentration was added; when higher concentrations 
were used the attachment was blocked efficiently.  This phenomenon has been also observed 
when anti-adherence experiments using bacterial pathogens have been performed. McGowan 
(2011, unpublished data) reported an increase of Salmonella Typhimurium adherence to Hep-2 
cells when GOS was added to evaluate its properties as an inhibitory agent. A possible 
explanation could be the formation of bridges between lectins in the culture cells’ surface, the 
free monosaccharides and the bacteria. However this theory has not been confirmed and seems to 
be improbable.  
In general, PDX blocked lectins attachment very poorly, suggesting that it is not an 
effective adherence inhibition agent and that it is structurally dissimilar to the HEp-2 receptor 
sites.  In contrast GOS was shown to be an efficient binding inhibitor. This observation elucidate 
why PDX has shown to be a poor inhibitor of bacterial adherence while GOS has been found to 
efficiently inhibit pathogens and their toxins to binding. Some examples include the inhibition of 
E. coli, E. sakazakii and Vibrio cholerae toxin adherence to epithelial cells and cell surface 
receptors  (Shoaf, et al., 2006; Sinclair et al., 2009; Quintero et al., 2011). 
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Table 1 . Plant lectins used in the study; source and carbohydrate specificity.  Rudiger and 
Gabius, 2002; Lis and sharon, 1986 ; Iskratsch et al., 2009; Chen et al., 2008; Munson et al., 1989 
 
 
 
 
 
 
 
Monosaccharides Glycans (*example of high specificity)
Con A Man/Glc  containing α linked Man
Concanavalin A *GlcNAcβ2Manα6(GlcNAcβ2Manα3)Manβ4GlcNAc
WGA
GlcNAc (low 
affinity) 
Dimers, Trimers ,oligosaccharides and glycoproteins 
containing GlcNAc, NeuNAc, (β4GlcNAc)2NeuNAc
Wheat Germ Agglutinin *GlcNAcβ4GlcNAcβ4GlcNAcβ4GlcNAcβ4GlcNAc
PNA Gal Galβ3GalNAc, Lactose
Peanut Agglutinin *Galb1,3GalNAc-Ser/Thr
RCA Gal oligosaccharides ending in Gal and NAcGal
Ricinus Communis Agglutinin I
β β ( β  
GlcNAcβ2Manα3)Manβ4GlcNAc
ECL Gal Galβ4GlcNAc
Erythrina Cristagalli Lectin *Gal(NAc)β4GlcNAc-R
EEL Galα3Gal
Euonymus Europaeus Lectin *Galα3(Fucα2)Galβ3/4GlcNAc 
SBA GalNAc/ Gal
Oligosaccharides with terminal α- or β-linked NAcGal/ Gal 
residues
Soybean Agglutinin 
UEA 1 Fu *Fucα6GlcNAc
Ulex Europaeus Agglutinin I
DBA GalNAc α linked NAcGal
Dolichos Biflorus Agglutinin *GalNAcα3GalNAcα3Galβ4Galβ4Glc
Dolichos biflorus
Ricinus communis 
(Euphorbiaceae)
Erythrina cristagalli
Euonymus europaeus 
(Celastraceae) -
Glycine max 
Ulex europaeus I
Lectin Plant Specie
Carbohydrate specificity
Canavalia ensiformis
Triticum vulgare
(Gramineae) 
Arachis hypogaea
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Figure 1. Microscopic images of HEp-2 cells after competition experiments (100X).Con A vs-G-
GOS. Amount of green is directly proportional to the amount of bonded lectin and inversely 
proportional to the percentage of inhibition.   
 
 
0 mg/ml 25 mg/ml 
50 mg/ml 100 mg/ml      c. 50 mg/ml   d. 100 mg/ml 
 
a. Control           b. 25 mg/ml 
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Figure 2. Lectins attachment inhibition by the action of cognate ligands and prebiotic 
carbohydrates. a. Erythrina Cristagalli Lectin (ECL), b. Peanut Agglutinin (PNA), c. 
Concanavalin A (Con A), d. Wheat Germ Agglutinin (WGA), d. Ricinus Communis Agglutinin I 
(RCA). 
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Figure 3. Structures of the prebiotic oligosaccharides used in the study. Glucose  ;  galactose 
 a. Galactooligosaccharides molecule, degree of polymerization between 2-6; containing 
glycosidic bonds: β 1-3, β 1-4, β 1-6. (GTC Nutrition, 2009) b. Polydextrose molecule. The R-
groups may be hydrogen,glucose, sorbitol, citric acid or a continuation of the polydextrose 
polymer; containing glycosidic bonds: all possible glycosidic bond, predominately α and β1-6; 
Average degree of polymerization 12 (Allingham 1982; Craig et al. 1999). 
 
 
 
 
 
 
Linkages  
β 1-3 
β 1-4 
β 1-6 
Linkages 
all possible glycosidic  
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a. GOS 
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Abstract 
The oligosaccharide (OS) fraction of human milk has several important biological 
functions in the neonate. These OS contribute to the development of the nervous system, 
stimulate the immune system, protect against bacterial and virus infections, and enhance growth 
of beneficial bacteria in the intestinal tract.  However, since human milk cannot be utilized as 
commercial source for these components, bovine milk and bovine colostrum by-products have 
been considered as potential sources of OS.  They contain some of the human milk OS, are 
available in high quantities, and are relative cheap. The existing extraction methods, which 
mainly involve removal of lactose and concentration of the oligosaccharides fraction, are limited 
and complicated. The goal of this project was to evaluate several different technologies for 
obtaining OS-rich fractions from bovine colostrum.  We tested nano-filtration, lactose 
crystallization, affinity chromatography, enzymatic hydrolysis, and bacterial fermentation as 
methods to degrade or remove lactose and/or separate oligosaccharides. Under the evaluated 
conditions, the physical-chemical separation methods were limited in their ability to enrich for 
OS from bovine colostrum. However nano-filtration was a promising option to achieve separation 
of simple sugars and OS, despite not being able to retain the OS within the retentate fraction.  
Microbial fermentation and enzymatic hydrolysis were effective methods for degrading lactose.  
 
Introduction 
Several important biological functions have been attributed to milk oligosaccharides, 
including improved gut health and protection against pathogens.  These reports have increased 
interest in obtaining large quantities of milk oligosaccharides for use as food additives and/or 
pharmaceutical constituents. In addition, non-milk OS that have structural similarities to the core 
molecules of HMO have also been studied (Moro et al. 2002; Bouhnik et al. 2004; Depeint et al. 
2008).  The latter include the galactooligosaccharides (GOS), OS derived from lactose via 
transgalactosylation reactions.  Both the milk-derived and lactose-synthesized OS are known to 
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have prebiotic activity, in that they specifically stimulate the growth of beneficial bacteria in the 
intestinal tract (LoCasio et al., 2007; Ward et al., 2007; Marcobal et al., 2010; Sela et al., 2011).  
They also provide postnatal stimulation of the immune system (Eiwegger et al., 2004; Braunstein 
et al., 1997; Recigno et al., 2009), and enhance defense against bacterial and viral infections 
(Kunz, et al., 2000, Morrow et al., 2005; Newburg et al., 2005; Bao et al., 2007). Although the 
process for obtaining non-milk bioactive carbohydrates is well established, the specific OS 
moieties generally differ only in length, which may limit their biological activity.  This is because 
it has been suggested that the activity or effectiveness of milk OS relies on the heterogeneity of 
the oligosaccharide fraction (Bode, 2006).  Thus, the more structurally diverse are the 
oligosaccharides, the greater will be their biological activity.  This may be especially evident in 
adherence inhibition, as heterogeneous OS would be expected to block pathogen adherence more 
effectively than a more homogenous mixture of OS.  In addition, a heterogeneous OS mixture 
may also serve as nutrients for beneficial bacteria with greater specificity, and thereby act as a 
more effective prebiotic. Nonetheless, for obvious reasons, human milk components are not food 
grade and their use in food systems would not be legal. Despite this restriction, there is still much 
interest in obtaining large amounts of human-like OS for food or pharmaceutical applications. 
Accordingly, several approaches have been considered, based on both in vivo and in vitro 
technologies. 
The first strategy relies on exploiting the the natural biosynthesis of milk OS in the 
mammary gland.  Although not all of the specific reactions are known, it is possible that HMO 
could be synthesized either in tissue culture (Ackland et al, 2001), transgenic animals (Prieto et 
al., 1995), or in genetically engineered bacteria (Priem et al., 2002).  However, these methods are 
biochemically rather complicated and would also require considerable regulatory review before 
they could be considered for human consumption products.  A second approach would be to 
identify animal species or breeds that produce milk with high levels of OS.  Animals that have 
been considered as a source of OS include elephants, goats, and cows.  Bovine milk has the 
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advantage of being produced in very high quantities and at low cost, especially whey.  However, 
the OS concentration is low in milk or whey. In contrast, bovine colostrum contains 10 times 
more OS than milk, and although the colostrum processing industry is not as developed as for 
bovine mature milk, there is still a large amount of colostrum sub-products available for use as a 
source of OS and other milk bioactive compounds. Another unique characteristic of bovine 
colostrum, in contrast with human milk, is the presence of NeuGc-linked OS. The consumption of 
NeuGc is associated with risk or incidence of disease. In effect, an excess of NeuGc intake 
provokes an immune response in adults (Varki, 2001). Further studies must to be done to 
establish if the presence of NeuGc in bovine milk limits the use of colostrum as source of OS. It 
is possible that NeuGc at low doses does not have heath implications but is still an efficient 
pathogen binding inhibitor. 
Several physical and chemical processes have been used to separate biologically or 
economically valuable OS compounds from milk.  These include chromatography, gel and 
capillary electrophoresis, selective precipitation and membrane technology. The only technique 
that has been efficiently implemented at a large scale, however, is membrane separation using 
either nano or conventional platforms (Sarney et al., 2000 ; Roth et al., 2001; De-Frees, 2002; 
Martinez-Ferez et al., 2006; Barile et al., 2009). In one of these studies, using whey obtained from 
Gorgonzola cheese production, as many as 115 different OS were identified, with 7 having the 
same composition as human milk OS (Barile et al., 2009). In another report, separation of lactose 
from the OS fraction was facilitated via nanofiltration combined with enzymatic treatment of 
lactose (Sarney et al., 2000). 
In this study, we used several methods to extract the OS fraction from bovine colostrum, and also 
assessed methods for direct degradation of lactose. 
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Material and Methods 
 
Carbohydrates. Sugars and glycans used in this study included glucose, galactose, lactose (all 
from Sigma Chemical Co., St. Louis, MO, USA) and galactooligosaccharide (GOS; Purimune, 
CornProducts International, IL, USA).  When large quantities of lactose were required, 
commercial refined lactose from bovine whey was used (Grande Cheese Company, Brownsville, 
WI, USA). 
 
Bovine colostrum samples and its fractionation procedure. Colostrum from one cow in early 
lactation (< 1 day) was provided by a local milk producer (Prairieland Dairy, Firth, NE). Milk fat 
was removed by centrifugation at 4°C and 1000 x g for 30 minutes. Skim colostrum was then 
mixed with 70% ethanol in a ratio of 1:1 to precipitate proteins. The mixture was allowed to stand 
for 1 hour at 4°C before it was centrifuged for 40 minutes at 4°C and 1000 x g. The resulting 
solution was held overnight and centrifuged again at the same conditions to get the maximum 
separation. Carbohydrate extracts were obtained by evaporating the ethanol using a roto-
evaporator R-205 (Büchi, Delaware, USA), followed by freeze drying the aqueous solution. 
Precipitated proteins were also dehydrated by lyophilization. The carbohydrate content of the 
powders was measured by the phenol-sulfuric colorimetric method (Chaplin and Kennedy, 1986); 
an FP-528 Nitrogen (LECO, St. Joseph, Michigan) nitrogen/protein analyzer was used to 
determine total protein content. 
  
Enzymatic Hydrolysis. β-Galactosidase (Aspergillus oryzae, Sigma) was used to hydrolyze 
lactose present in the carbohydrate fraction. Colostrum carbohydrate powder and 10 U of enzyme 
per gram of colostrum carbohydrate were dissolved in 50 mM sodium phosphate buffer (pH 6), 
filtered sterilized and incubated at 37°C with agitation during 120 hours. 
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Bacterial Fermentation. Lactobacillus spp. 1984, Lactobacillus helveticus ATCC 15009, and 
Lactococcus lactis subsp. lactis 404 were obtained from the University of Nebraska Lincoln stock 
culture collection.  MRS (Difco, MD, USA) broth and agar were used as growth media for 
Lactobacillus species and Elliker broth (Difco, MD, USA) was used for L. lactis. Two types of 
fermentation media were prepared and used during these experiments; both contained basal 
growth media-BGM (MRS or Elliker, without carbohydrate, depending on the microorganism).  
Carbohydrates, either GOS or the freeze dried colostrum extract, at a concentration of 2% (m/v) 
were added. Before each experiment, frozen stock cultures of each organism were thawed, plated 
onto the corresponding solid media and grown overnight at 37 C. Two more activations were 
carried out; a single colony was then inoculated into 10 ml of growth media, incubated overnight, 
and then inoculated at 1% (v/v) concentration into fresh media. To start the experiment, the 
fermentation media was inoculated (1% (v/v), and incubated at 37°C, in ambient atmosphere 
conditions without agitation, for 16 hours. Every 2 hours the OD (620 nm) was measured. pH was 
adjusted between 7.2 and 7.5 adding NaOH 0.2N to avoid over acidification and maintain cell 
growth. Simultaneously, at 4 hour intervals, fresh BGM was added to quadruple the volume 
contained in the fermentation flasks.   
 
Crystallization. Supersaturated colostrum carbohydrate solutions were prepared (0.24 g/ml). The 
solution temperature was increased to 90°C to dissolve lactose and then quickly decreased to 
30ºC.  Solutions were seeded with 1% pure lactose and placed in a water bath at 30ºC for 8 hours. 
Subsequently, tubes were held at 4ºC for 34 hours, then centrifuged for 20 min at 4ºC and 3200 x 
g.  The supernatant was freeze dried until 30% of the water was removed. Solutions were 
subjected to a second crystallization following the same procedure. 
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Affinity Chromatography. Columns (2 ml) were assembled using two types of commercial 
(Vector laboratories, Burlingame, CA, USA) agarose bound lectins, Phaseolus vulgaris 
erythroagglutinin (PHA-E) and Phaseolus vulgaris leucoagglutinin (PHA-L).  Colostrum 
carbohydrate extract was passed through the column, and then washed with PBS to elute non-
bound carbohydrates. Bound oligosaccharides were eluted using acetic acid (100 mM). The 
washed carbohydrates and eluted oligosaccharides fractions were collected and concentrated by 
lyophilization. 
 
Membrane Technology. A solution of 2% GOS and 20% refined lactose (Grande Cheese 
Company, Brownsville, WI, USA) was circulated through a GEA Model R filtration system using 
a dairy processing sanitary nanofiltration membrane (Model DL3840C-30, DESAL Membrane 
Products, GEA Filtration, Hudson, USA). The velocity of recirculation was set at 36 gal/min. The 
trans-membrane pressure was 15 psi and the temperature was held at 32°C to keep lactose in 
solution. The total process time was 40 minutes. 
 
Analytical Methods. Samples from the experiments described above were analyzed by thin layer 
chromatography (TLC), HPLC and MALDI-TOF MS.  However, the results for the latter two 
methods were inconsistent and will not be discussed. For TLC, silica gel plates (Aluminium 
sheets 20 x 20 cm, pore size 60 Å, EMD Millipore, Billerica, MA, USA) were used.  Plates were 
developed in a solvent containing 1-butanol, acetic acid, water (22:9:9).  
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Results 
Microbial fermentation. One strategy for removing lactose from lactose-OS mixtures is 
to rely on suitable lactic acid bacteria that preferentially ferment the lactose.  Two independent 
sets of experiments were performed, either with 2% of colostrum carbohydrates or a mixture of 
0.5% GOS and 2% lactose. Microorganisms were chosen based on previous experiments (Goin, 
2011), in which lactic acid bacteria unable to hydrolyze GOS were identified.  Accordingly, 
Lactobacillus spp. 1984, Lactobacillus helveticus ATCC 15009, and Lactococcus lactis subsp. 
lactis 404 were used in these fermentations.  Growth curves for both sets of fermentations showed 
that regardless of pH adjustment and the addition of nutrients (other than carbohydrates) bacteria 
populations did not increase  after 12 hours of fermentation (Figures 1 and 2).  Lactobacillus spp. 
reached higher cell counts when lactose and GOS were added to the media instead of the 
colostrum carbohydrates. The maximum OD reached by Lactobacillus when it was grown in 
MRS-colostrum carbohydrates was 30% lower than the maximum concentration reached in the 
GOS-lactose supplemented basal media.  When fermentation experiments were done using L. 
lactis, similar results were obtained. 
Samples were then analyzed by TLC (Figure 3).  Results showed that lactose concentrations 
decreased over time, disappearing after 16 hours. On the other hand OS concentration appeared to 
remain constant during the first 12 hours. After 16 hours, OS bands became fainter; however, 
these samples were 8-times more dilute that the earlier samples. 
Similarly, TLC of the 2% colostrum carbohydrate fermentation (Figure 4) also showed that 
lactose concentrations continuously decreased over time.  After 12 hours, no lactose was detected.  
The putative OS band remained present during the entire fermentation. After 16 hours the band 
appeared to become wider; however, this may have been due to the observed increase in viscosity 
of this solution.  
Enzymatic hydrolysis. Another approach for removing lactose from lactose-OS mixtures 
is via addition of beta-galactosidases that degrade lactose but not OS.  Enzyme-treated solutions 
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were prepared and analyzed by TLC.  At zero time, five bands could be differentiated in the 
untreated colostrum carbohydrate solution.  Bands corresponding to glucose and galactose are 
present on the top of the TLC plate, followed by the lactose band. The remaining bands 
correspond to OS (Figure 5). The lactose concentration clearly decreased over time, but was still 
apparent even after 120 hours of hydrolysis. In contrast, the intensity of the glucose and galactose 
bands increased during the experiment.  Two different OS bands were detected. The OS with the 
highest molecular weight remained constant during the experiment, whereas the apparent 
concentration of the low molecular weight OS decreased after 72 hours. In addition,  based on the 
retention factor, the low molecular weight OS detected at 72 and 120 hours appeared to be 
different from the one identified at time zero. 
Affinity chromatography. Lectin affinity columns, specific to OS, were used to separate 
and concentrate OS from lactose-OS solutions.  Based on the TLC results, the washed 
carbohydrates fraction (i.e. carbohydrates that did not bind to the column), contained lactose and 
OS.  The PHA-L washed fraction contained less carbohydrate than the washed fraction obtained 
with PHA-E.  Both were consistent with the concentration of the initial solution passed through 
the column.  Only one OS band was observed in the PHA-E eluted fraction, whereas no OS could 
be detected in PHA-L eluted fraction (Figure 6). 
Nano-filtration. Lactose-OS solutions were circulated through nano-pore membranes, 
and permeate and retentate samples were collected.  Samples before and during the circulation 
were obtained and analyzed by TLC (Figure 7). After accounting for the dilution, the 
concentrations of lactose and OS in the feed were the highest among the nano-filtration samples. 
In the three permeate samples, lactose was clearly detected.  In addition, however, GOS was 
observed in permeate fractions.  It appeared that both lactose and GOS were present at nearly the 
same concentration at each time point.  Retentate samples also contained lactose and GOS; based 
on band intensities, it appeared that both lactose and the OS were concentrated in the last fraction. 
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Crystallization. All obtained fractions, including the recovered crystals, contained 
lactose and oligosaccharides. In fact, the OS concentration of the final solution and the recovered 
crystals seemed to be nearly the same.  However, it was possible to remove some of the lactose 
by the crystallization method. Based, on TLC and accounting for the dilution factor, the lactose 
concentration in the final solutions was approximately 30 times less than the concentration in the 
initial solution. 
 
Discussion 
 Separating lactose from OS is technologically challenging due to their similar 
structures and size.  In this study, five methods were assessed for their ability to remove or 
separate the lactose fraction from bovine colostrum.  Although these methods were theoretically 
suitable for this application, none yielded OS-rich fractions from bovine colostrum.  
 Crystallization has long been used to remove lactose from milk, whey, and other dairy 
solutions (Leviton and Leighton, 1938; Nickerson and Moore, 1974; Kyle and Henderson,1970; 
Singh et al. 1991). However, when this method was used with the colostrum, a substantial amount 
of OS accumulated in the crystallized lactose fraction, reducing the OS concentration in solution. 
Evidently, it appeared that the crystallized lactose had physically trapped the OS molecules.  
 The use of membrane technology for separating lactose and OS in dairy mixtures is 
well established (Sarney et al., 2000 ; Roth et al., 2001; De-Frees, 2002; Martinez-Ferez et al., 
2006; Barile et al., 2009).  In this study, a nano-filtration approach using a membrane with a cut-
off of approximately 150-300 Dalton was carried out.  The pore size was large enough, however, 
to allow the OS to pass through at the same rate during the entire process.  Thus, the OS 
concentrations in the permeate samples (based on TLC) at different stages of the process were 
generally the same.  Similarly, the concentration of OS in the retentate sample did not increase 
either.  Although nano-filtration is a proven technology for separation of simple sugars and OS, 
appropriate membrane selection and optimizing operating parameters is essential. 
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 Affinity chromatography using ligand-specific lectins is a highly effective process for 
separating carbohydrates from mixtures.  In this study, two lectins (PHA-E and PHA-L) were 
chosen for their ability to bind complex oligosaccharides.  However, the cost of commercial lectin 
beads limited the size of the columns and the volume of colostrum solution that could be used.  
Dilute colostrum solutions were prepared, to ensure that the binding capacity of the lectins was 
not exceeded.  If lectins were saturated, then excess OS would pass through the column.  The 
significant amount of OS present in the washed fractions indicated that some or most of the OS 
were not bound to the lectin or had exceeded the lectin binding capacity.  Although the absence of 
TLC bands in the PHA-L eluted solution suggests that this lectin did not bind any of the OS, it is 
possible that PHA-L separated a minor fraction of OS that was not detected by TLC (OS 
concentration is less than the detection limit). Even if both lectins had been able to separate 
particular OS fractions, affinity chromatography using OS specific lectins may still not be a good 
approach to separate the carbohydrates from bovine colostrum, as several poterntially valuable 
OS could be lost in the separation process. A separation column using lectins targeting lactose 
instead of OS could be a better approach. However, if the lactose concentration in the colostrum 
fraction was very high, the lectins would be easily saturated and a significant amount of lactose 
would appear in the washed fraction. To completely remove lactose it would be necessary to 
either use large amount of immobilized lectins or subject the carbohydrate solution to multiple 
serial purifications. In addition, since milk OS contain lactose in their core molecule, lectins 
targeting lactose may also bind colostrum OS.  
 In contrast to generally ineffective methods based on physical separation of lactose 
from OS, lactose degradation methods were more effective. Two methods were considered, 
lactose hydrolysis and lactose fermentation.  A prolonged enzymatic hydrolysis with β-
galactosidase did hydrolyze lactose, as expected, but degradation of the low molecular weight OS 
also occurred (based on TLC). In order to optimize the process, it will be necessary to identify β-
galactosidases from different sources that have the highest selectivity towards lactose and 
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minimal or no activity on OS.  However, because OS hydrolysis occurred during extended 
incubation, an alternative approach would be to stop the treatment after 48 hours to degrade the 
maximum amount of lactose and keep the OS fraction intact. In fact, complete lactose 
degradation without appreciable changes in the OS profile was reported by Sarney et al. (2000) 
when they hydrolyzed lactose present in human, bovine, ovine and caprine milk during 5 hours.  
Ultimately, the lactose hydrolysis process still generates the monosaccharides, galactose and 
glucose, which must then be separated from the OS solution. Thus, enzymatic hydrolysis must be 
combined with another separation technique. Nanofiltration would be the best option since the 
hydrolysis increases the difference between the molecular weight of the sugars and facilitates a 
size-based separation. Indeed milk OS have been separated from a milk carbohydrates mixture 
after lactose was hydrolyzed by β-galactosidase (Sarney et al. 2000; Roth et al., 2001). 
 The fermentation method has the advantage of degrading lactose without the 
appearance of large quantities of monosaccharides. The main metabolite produced by LAB, lactic 
acid, can easily be neutralized. The efficacy of the bacterial fermentation methods was 
determined by TLC analysis.  However there are several other OS that could be degraded by the 
bacterial activity, especially the OS trimers. In the case that LAB could utilize OS, fermentation 
could be also stopped before lactose is completely depleted. LAB will ferment preferentially 
simple sugars; utilization of more complex sugars represents a major energy expense for the 
microorganism. According to previous studies of bovine milk OS characterization the glycan 
detected by TLC should be sialyllactose, which is the most abundant bovine acidic OS; it account 
for approximately the 30% of the total OS in bovine colostrum (Tao et al., 2009). 
 It is interesting that the oligosaccharide content of yogurt has been observed to 
increase during manufacture, suggesting that extracellular β-galactosidases from lactic acid 
bacteria (and different strains of Aspergilluus oryzae) might synthesize oligosaccharides by 
transgalactosylation (Toba et al., 1981, 1983 and 1986). Thus, it is possible that OS were 
synthesized in either the enzymatic hydrolysis or the bacterial fermentation processes. However, 
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this seems a rather remote possibility since the conditions required for OS synthesis are very 
specific. More likely, the lactic acid bacteria as well as the β-galactosidase used in the 
experiments did not synthesize OS.  It would be necessary to analyze the effects of the bacterial 
fermentation and enzymatic hydrolysis on each particular OS species to establish if OS are been 
degraded, synthesized or remained constant during each of these processes. 
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Figure 1. Growth curves of : a) Lactobacillus spp. 1984; b) L. helveticus ATCC 15009; c) L. lactis 404.  Growth media carbohydrates: 0.5% GOS 
and 2% Lactose. Drop in cell numbers at 8 and 12 hours is cause by the basal media addition .  
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Figure 2. Growth curves of : a) Lactobacillus spp. 1984; b)  L. lactis 404.  Growth media carbohydrates: 2% of colostrum carbohydrates. Drop in 
cell numbers at 8 and 12 hours is cause by the basal media addition .  
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Figure 3.  TLC of  0.5% GOS 2% lactose bacterial fermentation samples. 1, 4 and 12)  2% lactose and GOS standars; 3 to 5) L.lactis  
fermentation after 0, 12 and 16 h ; 6 to 8) Lactobacillus spp. fermentation after 0, 12 and 16 h ; 9 to 11)   Lactobacillus helveticus fermentation 
after 0, 12 and 16 h .Samples  of 0 h, 12 and 16 h  are 10,8 and 16 fold dilutions of the original carbohydrates solutions. 
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Figure 4.  TLC of 2% Colostrum CHOs bacterial fermentation samples. 1 and 2) 2% lactose and GOS standards; 3 to 6) replicates of L. Lactis 
fermentation after 0 and 8 hours; 7 to 10) replicates of Lactobacillus spp. fermentation after  0 and 8 hours; 11 and12) replicates of L. Lactis 
fermentation after 12 hours; 13 and 14) Lactobacillus spp fermentation after 12 hours. The latest samples (12 hours) are 2 fold dilutions of the 
original carbohdrates solutions. 
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Figure 5.  TLC of the colostrum CHOs ezymatic hydrolisis samples. 1 and 2) 2% glucose and galactose standards; 3 to 13) replicates of 
colostrum carbohydrates solution after 0, 24 , 48, 72 and 120 hours of hydrolysis; 14) Lactose standard.  
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Figure 6.  TLC of affinity chromatography 
samples.  1 to 4) 2% Glc, Gal, Lac and GOS 
standards . 5 and 6) Carbohydrates able to bind to 
PHA-E or PHA-L column after being 
eluted.Concentrated by 20 fold; 7 and 8) 
Carbohydrates unable to bind to PHA-E or PHA-
L column ; 9) colostrum carbohydrate fraction.  
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Figure 7.  TLC of nano-filtration samples. 1 to 4) 2% glucose, galactose, lactose and GOS standards; 5) Starting solution diluted by a factor of 
100 (I0); 6) Permeate at 252 psi system pressure (P0); 7) Permeate at 400 psi system pressure (P2); 8) Final permeate (PF); 9) Retentate. (R) 
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Figure 8.  TLC of crystallization samples.  1) correspond to  lactose standard; 2 and 3) Replicates of supersaturated initial solution (I0). Spotted 
samples are 10 fold dilution of the original carbohydrates solution; 4 and 5) Replicates of final solution after crystals removal (F); 6 and 7) 
Replicates of crystals recovered in the first crystallization (C1) ; 8and 9) Replicates of crystals recovered in the second crystallization (C2).  
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Chapter 4 
Adherence Inhibition of Enteric Pathogens to Epithelial cells by Bovine Colostrum 
Oligosaccharides and other bovine colostrum fractions 
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Abstract 
To initiate colonization and infection, most microbial pathogens must first recognize and adhere 
to cells in the host tissues. One suggested strategy for preventing infectious disease is based on adherence 
inhibition.  Exogenous carbohydrates that structurally resemble host cell receptor sites may act as decoys 
for bacterial adhesins and block pathogen adherence. Milk oligosaccharides and glycoconjugates have 
been shown to have this ability and can inhibit bacterial attachment. However, this bioactive property is 
based mostly on human milk oligosaccharides. In this study, in vitro competition experiments were 
performed to assess the anti-adherence properties of several bovine colostrum fractions against four 
enteric pathogens, enteropathogenic and enterotoxigenic Escherichia coli, Cronobacter sakazakii, and 
Salmonella enterica serovar Typhimurium. The UF permeate and the oligosaccharides fraction 
significantly inhibited binding of all four pathogens to HEp-2 tissue culture cells.  None of the other 
fractions decreased bacterial adhesion of either E. coli strains or C. sakazakii. In contrast, Salmonella T. 
attachment was also blocked by the NF retentate. The colostrum whey did not decrease adhesion. The 
results obtained from this study provided evidence to support the concept that bovine milk components 
can promote consumer health by preventing or reducing recurrence of infections and could be used as 
food additives and/or pharmaceutical constituents. 
 
Introduction 
For most bacterial pathogens, recognition and adhesion to the host cells are essential to initiate 
colonization and infection.  In order to adhere, bacteria have developed specialized structures positioned 
at the exterior of the cell called adhesins. Adhesins mediate highly stereospecific interactions of 
recognition and adherence with the host receptors. These adhesin-receptor interactions determine tissue 
tropism of the pathogen. For many bacterial pathogens, adhesins are considered as essential virulence 
factors. In fact, pathogens that have lost their ability to express adhesins become avirulent (Connell et al. 
1997; Klemm et al. 2006, 2007; Roos et al. 2006). 
Several different types of adhesin-receptor interactions of different chemical nature have been 
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recognized, however, the most common mechanism is the binding of bacterial lectins with carbohydrate 
moieties on the surface of the host cell.  This interaction accounts for the primary means by which 
adherence occurs among bacterial pathogens (Ofek et al. 2003). Accordingly, the prevention of bacterial 
adhesion is now regarded as a promising strategy for reducing infectious disease and overcoming the 
problems of bacterial resistance to antibiotics (Klemm et al., 2010). Several approaches have been 
evaluated, including the prevention of adhesin biosynthesis (Pinker et al., 2006; Åberg and Almqvist 
2007; Larsson et al. 2005; Pinkner et al. 2006; Svensson et al. 2001), the production of anti-adhesive 
vaccines (Rutter and Jones 1973; Langermann et al. 2003), and adhesion inhibition with receptor analogs 
(Bouckaert et al. 2005; Nagahori et al. 2002; Schembri and Klemm 2001). The latter is of great interest 
since several food natural components and synthesized additives have been shown to act as efficient 
inhibitors of pathogenic bacterial adherence. Among the food components that have been reported to have 
anti-adherence activity are several prebiotics, including GOS and FOS, mannan oligosaccharides, pectic 
oligosaccharides and milk glycoconjugates (Quintero el al., 2011; Kisiela et al. 2006; Ganan et al. 2010). 
The mechanism of action is based on the structural similarity between the exogenous glycans and the 
epithelial cell receptors. In the presence of soluble glycans, bacterial adhesins will bind to the free glycans 
instead of the host receptors. Ultimately, the pathogens will be flushed out by intestinal flow. 
Bovine milk glycans could be used as food additives and/or pharmaceutical constituents to 
prevent pathogen adherence, they resemble the receptors of host epithelial cells and therefore could act as 
efficient decoys. In addition, milk glycans constitute a heterogeneous mixture that may be an advantage in 
comparison with homogenous mixtures of prebiotic OS, as it has been suggested that the effectiveness of 
milk OS relies on the variety of glycan configurations. (Bode, 2006). Moreover, according to actual 
consumer trends, products containing natural components, such as milk fractions, could be easily 
accepted and preferred over products containing synthetic additives. 
Milk glycans that have shown pathogen anti-adherence activity include lactoadherin (Yolken et 
al., 1992; Newburg et al., 1998; Kvistgaard et al., 2004;), lactoferrin (Superti et al., 1997,2001; Quintero 
2011; Wang 2001; de Araujo and Giugliano, 2001), mucins (Schroten et al., 1992; Yolken et al., 1992; 
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Newburg et al., 1998; Kvistgaard et al., 2004;), gangliosides (Williams et al., 2005), and oligosaccharides 
(Martín-Sosa et al., 2002; Simon et al., 1997; Kunz, et al., 2000, Morrow et al., 2005; Newburg et al., 
2005; Bao et al., 2007). Furthermore, β-lactoglobulin and small peptides have also been shown to inhibit 
pathogen binding (Ouwehand et al., 1995; Ouwehand et al., 1997 and 1998; Bruck et al.2006).  Most of 
the attention has focused on milk oligosaccharides, since this fraction contains the greatest variety of 
carbohydrate species. Milk oligosaccharides consist of oligomer of 3 to 7 monosaccharides. Tri- and 
tetrasaccharides account for the majority of bovine milk OS.  About 40 different OS species have been 
identified in bovine milk.  Anionic OS account for about 70% of the total content, with sialyllactose as the 
most abundant (Tao et al., 2009).  In contrast to human milk, bovine colostrum contains N-
glycolylneuraminic acid and lacks fucose, which is common in human milk. It has been suggested that the 
main role of anionic OS is to block the adhesion of pathogenic bacteria to the epithelial surface whereas 
the neutral OS are responsible of the development of beneficial intestinal microbiota (Tao et al., 2009).  
Nonetheless, it has been demonstrated that several human milk fucosylated OS are able inhibit microbial 
adhesion, as well (Ruvoen-clouet et al., 2006; Morrow et al., 2004; Ruiz-Palacios et al., 2003). Therefore, 
neutral bovine milk OS may also act as efficient inhibitors.   
Bovine colostrum and its byproducts appear to be the best sources of bioactive compounds. 
Bovine colostrum contains 10 times more OS than mature milk (0.7-1.2 g/L), and although the colostrum 
processing industry is not as developed as for bovine mature milk, there is still a large amount of 
colostrum-derived products available. Another advantage of colostrum sweet whey is the presence of 
glycomacropeptide (GMP) that forms as a result of chymosin-mediated hydrolysis of kappa-casein.  GMP 
has been reported to be an effective adherence inhibitor agent (Neeser et al., 1994; Kawasaki et al., 1993; 
Simon 1996; Nakajima et al. 2005; Bruck et al., 2006).  
The goal of this study was to assess the anti-adherence properties of bovine glycans derived from 
colostrum and colostrum whey fractions using in-vitro competition experiments. 
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Material and Methods 
 
Bovine colostrum samples and oligosaccharides extraction. Colostrum from a single cow in early 
lactation (< 1 day) was provided by a local milk producer (Prairieland Dairy, Firth, NE). Milk fat was 
removed by centrifugation at 4°C and 1000 x g for 30 minutes. Skim colostrum was then mixed with 70% 
ethanol in a ratio of 1:1 to precipitate proteins. The mixture was allowed to stand for 1 hour at 4°C before 
it was centrifuged for 40 minutes at 4°C and 1000 x g. The resulting solution was held overnight and 
centrifuged again at the same conditions to obtain maximum separation. The carbohydrate-containing 
supernatant fraction was concentrated using a roto-evaporator R-205 (Büchi, Delaware, USA) to 
evaporate the ethanol and then lyophilized (Flexi-Dry FD-3-85A-MP, FTS Systems, Stone Ridge, NY). 
The precipitated proteins were also lyophilized. The carbohydrate contents of the dried fractions were 
measured by the phenol-sulfuric colorimetric method (Chaplin and Kennedy, 1986), and protein content 
was determined using an FP-528 Nitrogen (LECO, St. Joseph, Michigan) nitrogen/protein analyzer. 
 
Bovine colostrum whey fractions. Three bovine colostrum derived fractions were provided by Sterling 
Technology (Brookings, SD).  According to the manufacturer (Sterling Technology, personal 
communication), bovine colostrum (between 1 and 3 days of lactation) was treated with chymosin and the 
whey was collected and filter sterilized. This first fraction is referred to as colostrum whey. The whey was 
then filtered through a 10 KDa utltra-filtration membrane, and then the permeate was nano-filtrered using 
a 1 KDa membrane.  The permeate of the ultra-filtration (UF permeate) and the retentate of the nano-
filtration (NF retentate) correspond to the second and third analyzed fractions.   
 
Bacterial strains and culture conditions. Cronobacter sakazakii 4603 was obtained from K. 
Venkitanarayan (Department of Animal Science, University of Conneticut). ETEC strain ATCC 35401 
(H104:07) was obtained from Dr. Kuehn (Duke University).  EPEC strain E2348/69 (O127:H6) was 
obtained from M. Donnenberg (University of Maryland School of Medicine, Baltimore). Salmonella 
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enterica serovar Typhimurium was obtained from the University of Nebraska Lincoln bacterial culture 
collection. Tryptic Soy Agar and Broth (TSA and TSB; Difco) were used as growth media for EPEC, 
EPEC and C. sakazakii, and Luria Agar and Broth (LB and LA; Difco, MD, USA) were used for 
Salmonella. Before each experiment, frozen stock cultures of each organism were thawed, plated onto the 
corresponding solid media and grown at 37°C overnight. Two more activations were carried out; a single 
colony was inoculated into 10 ml of growth media, incubated overnight, and then inoculated at 1% (v/v) 
concentration into fresh media. A final transfer was done, and cells were incubated aerobically for either 4 
hours for C. sakazakii, 24 hours for Salmonella, or overnight for ETEC and EPEC.  Salmonella and C. 
sakazakii cultures were centrifuged at 3,184 g for 8 minutes, washed with phosphate-buffered saline 
(PBS) and re-suspended in minimal essential medium (MEM; Hyclone, Logan, Utah), supplemented with 
10% fetal bovine serum (FBS; Hyclone). For ETEC and EPEC experiments, overnight cultures were 
inoculated at 10% (v/v) in MEM supplemented with bovine serum and incubated for 80 minutes prior to 
the start of each experiment. MEM used for pathogen solutions was pre-equilibrated overnight at tissue 
culture conditions (5% CO2, 95% relative humidity, 37°C).   
 
Tissue culture conditions. HEp-2 (CCL-23) were obtained from the American Type Culture Collection 
(Manassas, Virgina) and maintained under tissue culture conditions in minimal essential medium 
(MEM/EBSS NEAA Modified, HyClone, Thermo Fisher Scientific Inc, Utah, USA) supplemented with 
10% fetal bovine serum (HyClone). For inhibition assays, subconfluent monolayers of HEp-2 cells were 
harvested with 0.25% (vol/vol) trypsin-EDTA solution (HyClone) and seeded in 24 well tissue culture 
plates at approximately 5 x 104 HEp-2 cells per well. Plates were incubated under tissue culture 
conditions for 30 hours before the experiment. 
 
Adherence inhibition assays. Sub-confluent HEp-2 cells were prepared as described above. Colostrum 
and colostrum fractions were mixed with the bacterial suspension previously prepared (see above), to a 
final concentration of 20 mg/ml of total carbohydrates or proteins. After washing the monolayers with 
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PBS, 500 µl of the potential pathogen-inhibitor solutions were added into each well. Cells were incubated 
at tissue culture conditions for 30 minutes for EPEC and 1 hour for ETEC, C. sakasakii and Salmonella T.  
Wells were then washed 5 times with PBS to remove non-adherent bacteria, followed by the addition of 1 
ml of 0.1% Triton 100x (Fisher, NJ, USA). After 30 minutes, cell de-attachment was completed and the 
contents were transferred to sterile centrifuge tubes for DNA extraction. In some of the experiments, 
microscopic counts were also obtained following the protocol described by Quintero (2011). Experiments 
were performed in triplicate. 
 
DNA Extraction and Real-time PCR assay for quantification. Bacterial DNA was extracted from 
material obtained in the adherence inhibition assays. Samples were centrifuged at 10,000 x g for 5 min 
and the pellet was re-suspended in 180 µl of buffer ATL from the DNeasy Blood and Tissue Kit (Qiagen, 
Hilden, Germany).  Instructions provided in the manufacturer’s manual for DNA extraction of Gram 
negative bacteria were followed to complete the extraction. Quantitative real time PCR (qRT-PCR) was 
performed using a Mastercycler Realplex2 (Eppendorf AG, Hamburg, Germany). Each PCR was done in 
a 25 µl volume. The reaction mixture comprised 11.25 µl of the 20x SYBR solution and 2.5-µl Real-
MasterMix (5Prime), 0.5 µM of each primer, and 1 µl of DNA template (Martínez et al. 2009). Specific 
primers and amplification program were followed for each organism (Table 1).  
 
Statistical analysis. Significant differences between the treatments were determined using one-way 
ANOVA.  Post hoc pair-wise comparisons were done using using Tukey’s test. Differences between 
treatments were considered significant when P-values were less than 0.05.  GraphPad Prism 5 (version 
5.03, GraphPad Software, Inc, 2010) was used to perform statistical tests and to generate graphical 
images 
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Results 
Colostrum carbohydrates fraction. The colostrum carbohydrate fraction showed significant 
adherence inhibition for all the pathogens evaluated (EPEC, ETEC, Salmonella Typhimurium 
and Cronobacter sakazakii ) (Figure1). The minimum required dose to reach a significant reduction was 
60 mg/ml, with the exception of E. sakazakii for which a dose of 80 mg/ml was necessary. The extent of 
the inhibition varied with the microorganisms. In general, colostrum carbohydrates were better inhibitors 
against EPEC and E. sakazakii. The highest level of inhibition observed, 99%, was obtained when these 
two pathogens were exposed to the colostrum carbohydrates.  In contrast, the maximum percentages of 
inhibition for ETEC and Salmonella T. were 83 and 89%, respectively (Table 2).  
A clear dose response was observed for EPEC adherence in the presence of colostrum 
carbohydrates (Figure 1a.). Bacterial attachment decreased progressively as the colostrum carbohydrate 
concentration increased. However, inhibition did not increase significantly beyond a dose of 110 mg/ml. 
For the other three microorganisms there was a “maximum effective dose”; after which an increase of the 
CHOs dose did not further significantly increase the inhibition.  The maximum effective dose was 60 
mg/ml for ETEC, 100 mg/ml for E. sakazakii and 80 mg/ml for Salmonella T.  
E. sakazakii behavior was unique among the organisms evaluated (Figure1c). When the lowest 
concentration was tested, the bacterial attachment increased. Nevertheless, the adherence in the presence 
of 60 mg/ml was not significantly different than the control and doses higher than 80 mg/ml significantly 
reduced adherence. The same behavior was observed in the microscopic counts, where an initial increase 
of adherence was followed by a significant decrease of attachment (data not shown). 
Because the samples contained significant amounts of lactose (approximately 80% of the total 
carbohydrate) lactose treatments where included in each of the experiments to establish if the inhibitory 
effect of the colostrum carbohydrates was due to the oligosaccharides, lactose, or both.  For those cases in 
which the lactose had a significant effect, different doses were tested. None of the E. coli strains were 
significantly inhibited by the highest dose of lactose. On the other hand, E. sakazakii and Salmonella T. 
were significantly inhibited by lactose for all the concentrations evaluated (Figures 1c and 1d). 
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Salmonella T. inhibition slightly increased as a result of the increase in concentration. In contrast, lactose 
inhibited E. sakazakii attachment to the same extent when exposed to 40, 60 and 80 mg/ml and 
significantly increased in the presence of 100 and 110 mg/ml. Lactose inhibition accounted for less than 
78% of the total inhibition of E. sakazakii and 64% of the total inhibition of Salmonella T.  Despite these 
observations, however, lactose would likely not act as a pathogen inhibitor in vivo because it would 
instead be hydrolyzed and absorbed before it reached the colon.  
Adherence inhibition by commercial colostrum whey fractions was tested against EPEC, E. 
sakazakii and Salmonella T.  However, the dried NF retentate could not be dissolved in saline solution, 
even after pH adjustment (7.1 - 7.3).  Therefore, this material was used in one of two ways: (1) using the 
entire fraction (including the insoluble part, which stayed in suspension during the incubation period); and 
(2) using only the soluble fraction of the NF retentate suspension (i.e., the solution resulting after pH 
adjustment and centrifugation).  The only fraction that inhibited adherence of all three microorganisms 
was the UF permeate (Figure 3).  Indeed, this fraction was more efficient than the colostrum carbohydrate 
fraction. Only 10 mg/ml of the UF permeate were necessary to observe significant inhibition of E. 
sakazakii and Salmonella T.  For EPEC, 20 mg/ml was found to be inhibitory (Table 2). 
The NF retentate inhibited attachment of Salmonella T. but not EPEC or E. sakazakii (Figure 4). 
This fraction achieved nearly the same levels of adherence reduction for Salmonella as the UF permeate 
(Table 2). Significant adherence reduction was reached with a minimum dose of 10 mg/ml. Therefore, the 
NF retentate was also more effective than the colostrum carbohydrate fraction. Although both the soluble 
and the complete NF retentate blocked Salmonella T. adherence, the soluble part of the NF retentate was 
less effective than the suspension (soluble and insoluble portion). A minimum dose of 60 mg/ml of 
soluble NF retentate was necessary to significantly inhibit Salmonella T. attachment (Figure 5). 
In contrast, the colostrum whey did not inhibit pathogen attachment at any of the concentrations 
tested. None of the three pathogens evaluated was inhibited by this fraction. Similarly, the NF retentate 
did not inhibit either EPEC or E. sakazakii binding to HEp-2 cells. This behavior was observed for both 
subsets of experiments carried out with this fraction (i.e. soluble portion and entire suspension). 
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 Discussion  
In vitro tissue culture experiments were conducted to assess the anti-adherence properties of 
bovine colostrum fractions against EPEC, ETEC, C. sakazakii, and  S. Typhimurium.  A total of four 
fractions were evaluated, including colostrum whey, UF permeate, NF retentate and a colostrum 
carbohydrate fraction. The UF permeate and the carbohydrates fraction significantly inhibited binding of 
all four pathogens to HEp-2 tissue culture cells, whereas the NF retentate was inhibitory only to 
Salmonella.  The colostrum whey did not decrease adherence for any of the test organisms (Figure 2). The 
activity of the effective fractions was mainly attributed to the presence of OS and/or GMP.  However, 
lactose and peptides may have also contributed to the adherence inhibition we observed. 
Since the mechanism of adherence inhibition depends on the structural similarity of the test 
glycans to the cognate epithelial cell receptors for the bacterial adhesins, the carbohydrate fraction of 
colostrum oligosaccharides were the first to be evaluated. Our results confirm the findings of previous 
studies in which bovine milk OS were shown to be capable of inhibiting bacterial adhesion. Helicobacter 
pylori was inhibited by 3’-sialyllactose, 6’-sialyllactose and 6’-sialyllactosamine isolated from bovine 
milk, with 3’sialyllactose as the most active OS (Simon et al., 1997). Similarly, sialylated 
oligosaccharides were also shown to be effective inhibitors of UPEC and ETEC strains.  However human 
milk OS had greater binding inhibition than bovine OS for ETEC. (Martín-Sosa et al., 2002).  
 It has been suggested that the two main types of OS that are responsible for pathogen 
inhibition are the sialylated and fucosylated OS.  This is because the principal targets for viruses and 
bacteria are fucose- and sialic acid-containing glycans (Bohem and Moro, 2008). In fact, studies using 
human milk OS suggest that both neutral and acidic OS are able to inhibit bacterial and virus attachment 
(Chichlowski et al., 2010; Ruvoen-Clouet et al., 2006).  However, since bovine colostrum lacks 
fucosylated OS and the acidic OS fraction accounts for more than 70% of the total bovine colostrum OS, 
the pathogen inhibition observed in this study can be attributed mainly to the colostrum anionic OS.  
 On the other hand, the colostrum whey besides carbohydrates also contained proteins, 
including lactoalbumin, lactoglobulin, bovine serum albumin, lysozyme, gangliosides, lactoferrin, GMP, 
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and lactoadherin. Several of these components have been shown to have anti-adherence properties (de 
Araujo and Giugliano, 2001; Kvistgaad et al., 2004; Newburg et al., 1998; Ouwehand et al., 1997). 
However, their anti-adherence activity has been mostly established using fractions or pure components 
derived from human milk.  Limited evidence exists of the activity of the bovine counterparts. Bovine 
lactoferrin anti-adherence activity was demonstrated using a mouse model, and independent of the iron-
scavenging properties, lactoferrin was also able to inhibit H. pylori attachment to the stomach mucosa 
(Wang et al. 2001). β-lactoglobulin extracted from infant formula inhibited Klebsiella oxytoca and SfaII-
expressing E. coli adhesion (Ouwehand et al., 1997 and 1998). Other reports are less consistent. For 
example, some studies suggest that bovine lactadherin does not inhibit pathogen binding (Kvistgaard et 
al., 2004), whereas Kanamaru et al., (1999) showed that lactadherin inhibited adherence of human 
rotavirus.  Finally, as noted previously, certain anionic bovine OS have been shown to be effective 
blocking agents, and our results suggest that even if some of these compounds have anti-adherence 
properties, the concentration in which they are present would likely not be high enough to significantly 
inhibit any of the pathogens tested. A particular case that supports our hypothesis is lactoferrin.  Quintero 
(2011) established that a minimum dose of 10 mg/ml of lactoferrin was required to obtain a significant 
inhibition of E. sakazakii to Hep-2 cells (unpublished data).  The concentration of lactoferrin in bovine 
colostrum is up to 1.5 mg/ml (Yekta et al. 2010); even if the microfiltration treatment achieved a partial 
water removal, lactoferrin concentration would not be close to 10 mg/ml. 
 In the ultra-filtration step, proteins were removed, and therefore, the UF fraction contains 
carbohydrates, peptides and small glycoproteins such as GMP. The inhibitory effect of this fraction (UF 
permeate) can be attributed mainly to OS and GMP. Bovine GMP has been suggested to contain 
carbohydrate moieties that inhibit bacterial and viral infection.  Nakajima et al. (2005) reported that 
sialylated GMP inhibited adherence of Salmonella Enteridis and E. coli O157:H7. Specifically, GMP 
containing the NeuAca2-3Gal41-3GalNAc trisaccharide has been reported to prevent E. coli 
hemaglutination (Parkkinen et al. 1986). Bruk et al (2006) observed that GMP (0.25 mg/ml) reduced 
association of EPEC and Salmonella T. to CaCo-2 cells. Similarly, Halpin et al. (2009) attributed the 
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ability of several whey commercial products to inhibit the adhesion of Salmonella T. E. coli O157:H7 and 
E. sakazakii (to CaCo-2 cells) to the activity of GMP. Furthermore, GMP is also able to inhibit virus and 
non-enteric bacteria. For example, hemagglutination of four different strains of human influenza virus 
was inhibited by the addition of GMP (Kawasakii et al. 1993). Furthermore, adhesion of carcinogenic 
bacteria (Streptococcus mutans, S. sanguis, S. sobrinus and Actinomyces viscou) to oral surfaces was 
inhibited by GMP (Neeser et al. 1994).  
 Additional interfering compounds present in the UF permeate include lactose and small 
peptides. Lactose at high concentrations was found to contribute significantly to the inhibition effect for 
E. sakazakii and Salmonella T.  Naturally occurring free peptides or peptides liberated from other proteins 
could also have contributed to adherence inhibition.  Bruck and collaborators (2006) showed that free 
peptides liberated from GMP significantly reduced association levels of EPEC. Indeed, it has been 
suggested that the activity of peptides encrypted within bioactive proteins remains latent until they are 
subjected to proteolytic action of the enzymes (Sinha et al., 2007).   However, the concentration of 
peptides should be very low in relation with the other active molecules.  
 The combined activity of OS, GMP and lactose could explain why the UF permeate had 
higher adherence inhibition than the colostrum carbohydrates fraction. The UF permeate contained a 
greater diversity of biologically-active glycans that were potentially capable of inhibiting multiple 
adhesins.  GMP-bound glycans contain N-acetylgalactosamine, N-acetylglucosamine, fucose and sialic 
acid, among others (reviewed in Brody, 2000). Thus, GMP has the ability to inhibit adhesins specific for 
fuscosylated glycan receptors, a property not achieved using bovine OS, exclusively.  In the particular 
case of E. sakazakii, UF permeate was an especially effective inhibitor compared to the colostrum 
carbohydrates. Only 10 mg/ml of UF permeate was necessary to reach significant inhibition whereas 80 
mg/ml of colostrum carbohydrates were required. These findings suggest that GMP is a more efficient 
inhibitor of E. sakazakii attachment than OS.  
 The final filtration was intended to remove lactose and concentrate the bioactive compounds. 
However, when the obtained retentate was tested it was found to have limited inhibition activity, as only 
105 
 
Salmonella T. was inhibited. There are several possible explanations for this result. The first is that the 
smallest OS were able to pass through the membrane and were removed along with the lactose. Thus, the 
amount of inhibitory compounds in the sample decreased substantially. In fact, sialyllactose, the most 
abundant OS present in bovine colostrum (Tao et al., 2009), has a molecular weight of 633 Da. Therefore, 
this compound was likely lost during the nanofiltration process, as only an electric repulsion between the 
acidic OS and the membrane could have prevented the OS from crossing the membrane. The second 
explanation is that some unidentified compounds present in the fraction could have interfered with the 
bioactive molecules, reducing their inhibitory effect. In addition, it is possible that some of the glycans 
had aggregated during the drying operation.  The fact that such molecules did not get into solution implies 
that the bioactive sites were not completely exposed, diminishing their inhibition capacity. Therefore, the 
drying process must be optimized to increase the powder solubility and prevent the loss of activity due to 
lack of solubility. 
 The observation that the NF retentate and the UF permeate inhibited Salmonella with the same 
effectiveness, suggest that the component responsible for the inhibition of this microorganism was not 
lost in the filtration process and was present in NF retentate. Based on the previous discussions, this 
compound is more likely GMP.  However, complementary studies have to be done to validate this 
hypothesis. Interestingly, the soluble portion of the NF concentrate was a less effective inhibitor than the 
complete fraction. Although precipitation of the insoluble fraction was not observed during the incubation 
period, it is possible that a microscopic layer of insoluble molecules formed over the cells preventing the 
bacteria to interact with the receptors.  
 The results obtained from this study provide evidence to support the concept that bovine milk 
components can promote consumer health by preventing or reducing enteric infections.  These 
constituents could be used as antimicrobial agents in foods and/or in pharmacological application. In 
particular, bovine colostrum whey appears to be a suitable source for these compounds. The concentration 
of glycans in colostrum is higher and more diverse than in mature milk. In addition, the chymosin 
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treatment increases the biological activity by releasing natural occurring glycan species that are present as 
part of complex molecules. 
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Organism Primers (5’ -  3’) Amplification Program 
EPEC 
eaeFor  GGCGATTACGCGAAAGATAC Initial denaturation at 95°C for 10 min and 40 cycles at 95°C 
for 15s and 62°C for 1 min for 
annealing and extension. eaeRev GATTAACCTATGCCGTTCCA 
ETEC 
STa-F 
GCTAATGTTGGCAATTTTTATTTCTGTA 
STa-R 
AGGATTACAACAAAGTTCACAGCAGTAA 
Initial denaturation at 95°C for 
10 min and 40 cycles at 95°C 
for 15s and 55°C for 10s for 
annealing and extension. 
C. sakazakii For  TATAGGTTGTCTGCGAAAGCG Rev GTCTTCGTGTGCGAGTTTG 
Initial denaturation at 95°C for 
10 s, 45 cycles at 95°C for 5 s, 
62°C for 20 s for annealing 
and extension. 
Salmonella 
Typhimurium 
139 -GTGAAATTATCGCCACGTTCGGGCAA Initial denaturation at 94°C for 2 min and 45 cycles at 94°C 
for 20s and 62°C for 1 min for 
annealing and extension 
141 -TCATCGCACCGTCAAAGGAACC 
 
Table 1. Primers and PCR programs for the different organisms used in this study. 
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Figure 1. Adherence of a. EPEC, b. ETEC, c. E. sakazakii, and d. Salmonella T. to HEp-2 cells in the presence of different doses of colostrum 
carbohydrates and pure lactose  113 
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Figure 2. Adherence of a. EPEC, b. E. sakazakii, and c. Salmonella T. to HEp-2 cells in the presence of different doses of the micro-filtrated 
colostrum whey  
114 
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Figure 3. Adherence of a. EPEC, b. E. sakazakii, and c. Salmonella T. to HEp-2 cells in the presence of different doses of the ultra-filtration 
permeate   
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Figure 4. Adherence of a. EPEC, b. E. sakazakii, and c. Salmonella T. to HEp-2 cells in the presence of different doses of the nano-filtration 
retentate   
116 
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Figure 5. Adherence of a. EPEC, b. E. sakazakii, and c. Salmonella T. to HEp-2 cells in the presence of different doses of the nano-filtration 
retentate soluble portion 114 
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Table 2. Summary of the relevant percentage of inhibition obtained during the anti-adherence experiments. 
Statistically significant effects compared to control (p<0.05) are indicated by the asterisk.  
 
 
 
 
 
 
 
 
 
 
 
 
Lactose 40 mg/ml 60mg/ml 80mg/ml 100mg/ml 110mg/ml
EPEC 55,84 69,10 88,64 91,80 98,38 98,88
ETEC -23,83 54,50 77,68 83,63 82,46 82,62
E. sakazakii 84,74 -338,14 4,96 82,45 99,08 99,18
Salmonella T. 72,50 23,41 53,35 86,32 85,55 89,47
Lactose 5 mg/ml 10 mg/ml 20 mg/ml 40 mg/ml 60 mg/ml
EPEC 55,84 33,73 61,75 93,31 94,74 97,19
Lactose 10 mg/ml 15 mg/ml 20 mg/ml 40 mg/ml 60 mg/ml
E. sakazakii 51,38 68,86 67,89 85,75 78,92 78,14
Salmonella T. 29,88 69,11 94,09 96,03 98,43 98,67
Lactose 10 mg/ml 15 mg/ml 20 mg/ml 40 mg/ml 60 mg/ml
Salmonella T. 29,88 70,81 90,19 90,23 87,15 97,29
Lactose 20 mg/ml 40 mg/ml 60 mg/ml 80 mg/ml 100 mg/ml
Salmonella T. 52,88 -39,82 28,71 74,68 86,85 92,15
Colostrum CHOs
UF Permeate
NF Concentrate
NF Concentrate 
soluble portion
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* * * 
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Chapter 5 
Conclusions 
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In this study we proposed a simplified model using plant lectins to simulate bacterial adhesins-receptor 
interactions.  The results confirmed our hypothesis that bacterial binding inhibition is caused by exogenous 
oligosaccharides that are structurally similar to the cognate ligands.  In addition, bovine colostrum was 
demonstrated to be a suitable source of bioactive glycans that are able to inhibit the adherence of 
enteropathogenic Escherichia coli, enterotoxigenic Escherichia coli, Enterobacter sakazakii and Salmonella 
enterica serovar Typhimurium to epithelial cells. Several methods for the extraction of milk oligosaccharides 
and degradation or removal of lactose were assessed.  Enzymatic hydrolysis and microbial fermentation were 
effective for degrading lactose, and could be considered as viable approaches for separating lactose from the 
bioactive oligosaccharides. The major findings of this research are described below. 
 
• Based on lectin-ligand competition assays, the glycan composition of the Hep-2 cells surface was 
predicted to contain glucose, galactose, α linked mannose, N-Acetyl glucosamine, dimers or 
oligosaccharides containing N-Acetylglucosamine and/or glycans with the linkages galactose(β-1,3)N-
Acetylgalactosamine or galactose (B1-4)N-Acetilglucosamine. 
 
• All the lectins that were able to bind to the HEp-2 cells were inhibited by nearly 100% in the presence of 
cognate ligands, and when prebiotics were added, inhibition of lectin binding also was observed. The 
greater the similarity between the prebiotic and the cognate ligands, the greater was the inhibition that 
was observed. 
 
• GOS significantly inhibited most of the lectins, which support the role of GOS as an efficient anti-
adherence agent.  In contrast, PDX did not inhibit lectin attachment, suggesting that it is not effective as 
an adherence inhibition agent. 
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• Under the evaluated conditions, the physical-chemical separation methods (crystallization, affinity 
chromatography and nano-filtration) were limited in their ability to enrich for OS from bovine 
colostrum. However, nano-filtration was a promising option to achieve separation of simple sugars and 
OS, despite not being able to retain the OS within the retentate fraction. 
 
• Enzymatic hydrolysis and microbial fermentation were effective methods for degrading lactose, 
although the effect of these treatments on oligosaccharides will need further analysis.  
 
• Bovine colostrum contained fractions that significantly inhibited binding of all four pathogens to HEp-2 
tissue culture cells.  An ultrafiltration permeate was the most effective inhibitor due, we suggest, to the 
greater diversity of biologically-active glycans contained in this fraction. 
 
• A nanofiltration retentate had inhibitory properties only against Salmonella, and a colostrum whey 
fraction did not decrease adherence for any of the test organisms.  
 
• The activity of the effective fractions was mainly attributed to the presence of oligosaccharides and/or 
peptides.  However, lactose may have also contributed to the observed adherence inhibition. 
 
• The results obtained from this study provide evidence to support the concept that bovine milk 
components can promote consumer health by preventing or reducing enteric infections.  These 
constituents could be used as antimicrobial agents in foods and/or in pharmacological applications. In 
particular, bovine colostrum whey appears to be a suitable source for these compounds.  
 
